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CHAPTER 1. GENERAL INTRODUCTION 
Dissertation Organization 
Immunoassays have been utilized for the detection of biological analytes for several 
decades. Many formats and detection strategies have been explored, each having unique 
advantages and disadvantages. More recently, surface-enhanced Raman scattering (SERS) 
has been introduced as a readout method for immunoassays, and has shown great potential to 
meet many key analytical figures of merit. This technology is in its infancy and this 
dissertation explores the diversity of this method as well as the mechanism responsible for 
surface enhancement. Approaches to reduce assay times are also investigated. Implementing 
the knowledge gained from these studies will lead to a more sensitive immunoassay requiring 
less time than its predecessors. 
This dissertation is organized into six sections. The first section includes a literature 
review of the previous work that led to this dissertation. A general overview of the different 
approaches to immunoassays is given, outlining the strengths and weaknesses of each. 
Included is a detailed review of binding kinetics, which is central for decreasing assay times. 
Next, the theoretical underpinnings of SERS is reviewed at its current level of understanding. 
Past work has argued that surface plasmon resonance (SPR) of the enhancing substrate 
influences the SERS signal; therefore, the SPR of the extrinsic Raman labels (ERLs) utilized 
in our SERS-based immunoassay is discussed. 
Four original research chapters follow the Introduction, each presented as separate 
manuscripts. Chapter 2 modifies a SERS-based immunoassay previously developed in our 
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group, extending it to the low-level detection of viral pathogens and demonstrating its 
versatility in terms of analyte type. Chapter 3 investigates the influence of ERL size, material 
composition, and separation distance between the ERLs and capture substrate on the SERS 
signal. This chapter links SPR with SERS enhancement factors and is consistent with many 
of the results from theoretical treatments of SPR and SERS. Chapter 4 introduces a novel 
method of reducing sample incubation time via capture substrate rotation. Moreover, this 
work led to a method of virus quantification without the use of standards. Chapter 5 extends 
the methodology developed in Chapter 4 to both the antigen and ERL labeling step to 
perform assays with improved analytical performance in less time than can be accomplished 
in diffusion controlled assays. This dissertation concludes with a general summary and 
speculates on the future of this exciting approach to carrying out immunoassays. 
Literature Review 
Traditional Immunoassays 
Immunoassays are a class of analytical methodology that relies on the interaction of 
an antibody with its target antigen. This methodology was developed in the early 1960's for 
monitoring insulin,1 and at that time its impact on the biological sciences was largely 
unappreciated. Breakthroughs in analytical readout technologies with improved sensitivity, 
coupled with immunoassay formats, facilitated the detection of lower levels of biochemically 
important molecules and led to significant clinical chemistry and medical discoveries. Today, 
immunoassays are routinely used in veterinary and human health diagnostic labs for early 
disease diagnosis and treatment in an effort to prevent the spread of contagious diseases and 
decrease the length of hospitalization. Immunoassays have also been applied to food 
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safety3"5 and environmental analysis,6"1' and have more recently been called upon to help 
fight the war against bioterrorism.12 Further optimization of immunoassays in terms of 
sensitivity, specificity, speed, and throughput will likely generate more breakthroughs in all 
branches of science. Gaining further insights into fundamental and technical aspects of 
immunoassays has therefore been the focus of many research groups. 
The antibody is the principal component in all immunoassays. Antibodies are proteins 
in the immunoglobulin (Ig) class, produced in vivo and can be further classified into the 
subgroups IgG, IgA, IgM, IgD, and IgE.13'14 All of the work presented in this dissertation 
employ IgG antibodies. Immunoglobulins are a special type of protein that possess binding 
sites specific for a target antigen. X-ray crystallographic studies suggest that the binding site 
of the antibody, or the paratope, is approximately 2 x 2 x 1 nm.13 The specificity of the 
interaction between the binding site and the epitope, the portion of the antigen that is 
recognized by the paratope, results from complementary physical shape and charge. It has 
been estimated that >600 A of the epitope is buried in the paratope upon binding. 
Electrostatic, hydrophobic, hydrogen, and Van der Waals interactions stabilize the antibody-
antigen complex at 15-22 amino acid points of contact on the antibody.13 These forces lead to 
typical equilibrium constants for the reaction between the antibody and antigen to form the 
complex (i.e., antibody-antigen affinity constants) ranging from 107 to 1012 M"1.14 
Collectively, it is the specificity of the antibody binding site and the strong affinity of the 
antibody-antigen complex that we exploit as analytical chemists. 
In general, immunoassay formats can be divided into two categories, competitive and 
noncompetitive. Competitive immunoassays rely on the competition between a labeled 
analyte (i.e, tracer) and the sample analyte for a limited number of antibody binding sites. 
After incubation, the concentration of the tracer (bound or free) is measured and related to 
the sample concentration. Noncompetitive immunoassays rely on an excess of antibody to 
effectively drive exhaustive binding of the analyte to the antibody-antigen complex. The 
complex is then quantified and related to antigen concentration. This complex is often 
measured with the use of a tracer (labeled secondary antibody) which binds to another 
epitope on the bound antigen. Each of these formats is illustrated in Figure 1. 
B 
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Antibody Antigen Labeled 
Antigen 
(i.e., tracer) 
Labeled 
Secondary Antibody 
(i.e., tracer) 
Figure 1. (A) Competitive and (B) Noncompetitive immunoassay formats. 
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Theoretical assessment of detection limits for each of the immunoassay 
configurations can be conducted using typical values for the immunocomplex binding 
affinity and other contributing parameters. The detection limit in a competitive immunoassay 
is governed by the affinity constant and the error in the measurement. This is because lower 
analyte concentrations result in greater tracer binding in a typical competitive assay, yielding 
higher signals. Thus, the brightness of the label is not a significant factor for the detection of 
low concentrations. It is the variation in this high signal that is important, as the signal 
uniformity increases, the ability to detect a small decrease in signal increases. Moreover, 
large binding affinity constants ensure that the analyte preferentially binds to the antibody 
over the tracer. Assuming the highest possible binding affinity (Ka = 1012 M"1) and a 1% 
variation in the blank signal, the detection limit in a competitive immunoassay is ~10"14 M.13, 
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The detection limit in a noncompetitive assay is controlled by not only the affinity 
constant and experimental error but also by the detectability of the tracer and nonspecific 
binding of the labeled secondary antibody. In this format, an analytical signal should only be 
obtained when analyte is present; thus, low levels of analyte yield low signals. Therefore, the 
drive to detect even lower levels an antigen continues to push the development of brighter 
labels. Nonspecific binding of a tracer to a capture antibody in the absence of analyte will 
trigger an undesirable response. If nonspecific binding occurs, the tracer can affect the 
detectable signal at low analyte concentrations and result in the inability to distinguish 
analyte generated signal (i.e., specific binding of the tracer to the analyte) from erroneous 
signal (i.e., nonspecific adsorption). Thus, higher analyte concentrations are required to 
generate a statistically significant signal from that of the background. A great deal of effort 
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has been placed on decreasing nonspecific binding by the use of surfactants, to decrease 
nonspecific protein-protein interactions, and blocking agents, in the case of a solid phase 
immunoassay to reduce nonspecific tracer-solid phase interactions. Assuming a Ka of 1012 M" 
', a 1% deviation in the blank signal, and a 1% level of nonspecific binding, the detection 
limit can be two orders of magnitude lower than a competitive assay.13'15 Unlike a 
competitive assay, however, the noncompetitive assay can be improved with better secondary 
labels and a decrease in nonspecific binding. 
Quantification of the immunocomplex in both the competitive and noncompetitive 
formats typically requires the separation of the antibody-antigen complex from labeled, 
unreacted antibodies in solution. Although it is possible for the immunoreaction to trigger a 
change in the signal of some tracers, thereby allowing separation-free quantification of the 
complex, this type of readout is less common. 
A convenient method to separate free and bound reactants is to immobilize the bound 
form on a solid phase and wash away unreacted immunoreagents. Traditional solid phases for 
antibody or antigen immobilization include plastic microtiter plates, polymer beads, and 
membranes.13 Immobilization to these substrates usually relies on hydrophobic or 
hydrophilic adsorption, although covalent attachment can be achieved with functionalized 
surfaces. A thorough list of traditional solid phases, modes of immobilization, and 
performance has been compiled by Diamandis and Chrostopoulos.13 
Gold and glass substrates are among the more recent examples of substrates that serve 
as solid phases for immunoassays. Gold surfaces can be chemically modified by the 
spontaneous adsorption of thiols and disulfides. " The monolayer precursors are selected 
such that the functional moiety of the co-terminus of the monolayer will react and covalently 
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bind to antibody or antigen molecules.19"24 Similarly, silanes can be used to modify glass 
surfaces to impart a particular functionality that will covalently bind proteins. 
Several readout methods have been developed to quantify the antibody-antigen 
immunocomplex after separation of the free and bound tracer. Established analytical labels 
for tracers include radioactive isotopes, enzymes, fluorophores, and chemiluminescent 
labels.13'14,28~30 While these readout techniques have been extensively studied and have 
found routine use in immunoassays, each has unique strengths and weaknesses. 
Radioactive isotopes were once the most heavily used label for tracers in 
immunoassays. Radioimmunoassays rely on the disintegration of unstable radioisotopes 
covalently grafted onto a tracer antibody or antigen. The counted radiation can be either a 
/^-particle or a ^-ray, although ^-emitters are preferred due to greater activities and simpler 
instrumentation for detection. Further, radioactive decay is not affected by environmental 
factors such as pH or ionic strength and low radioactive backgrounds in biological matrices, 
which facilitate high sensitivity, led to the success of these assays. The most commonly 
employed isotopic label is the ^-emitter, 125I. The use of other isotopes as labels has been 
explored in an effort to find isotopes which emit unique emission spectra. This development 
would allow the use of multiple labels to simultaneously detect multiple analytes; however, 
isotopic labels emit over a broad energy range. Thus, multi-analyte detection with distinctive 
isotopic labels always results in interference due to overlapping spectra.31 Moreover, health 
hazards associated with radioisotope exposure has led to the diminished use of 
radioimmunoassays.32'33 
Enzymes were introduced in the 1970's as an alternative to radioisotope labels34'35 
and currently rank as the most widely used label in immunoassays. In an enzyme-linked 
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immunosorbant assay (ELISA), the enzyme is conjugated to an antibody or antigen tracer, 
and following the immunoreaction and separation steps, a substrate which reacts with the 
enzyme is added to the reaction vessel. The product of the enzyme-substrate reaction is then 
quantified with a variety of methods, including visual assessment, colorimetry, fiuorimetry, 
luminometry, and electrometry.1 '14 In addition to the great flexibility in enzyme and readout 
choice, ELISA offers the advantage of high sensitivity due to the inherent amplification 
resulting from the high turnover rates of enzymes. Horseradish peroxidase and alkaline 
phosphatase are two of the most popular enzyme labels because of their high turnover 
numbers. 
There are, however, some disadvantages with enzymatic labels. First, enzymes are 
large molecules with small diffusion coefficients. The large size translates to slow diffusion 
rates of the tracer and long sample incubation times are required. The macromolecular 
properties of the enzyme resemble those of antibodies which are favorable for adsorption to 
solid phases or sticking to the protein modified substrate. This propensity places enzymatic 
labels at a greater risk of nonspecifically binding to a solid phase than small molecule labels 
and can result in high backgrounds causing the limit of detection to suffer. Enzymes are also 
sensitive to environmental conditions such as pH, ionic strength, and temperature, which may 
alter their activity and this environmental dependence is typically an undesirable 
characteristic for a label. In some special cases the binding of an antigen to an enzyme-
labeled antibody causes conformational changes in the enzyme, inhibiting its activity and 
serving as a basis for monitoring immunocomplexes without a separation step of the free and 
labeled reagents.36 
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Multiplexing is another challenge for enzyme-based assays. As described above, the 
enzyme-substrate products typically result in a color change or emitted radiation and are 
readout spectroscopically. The challenge is finding multiple enzyme-substrate systems that 
generate products without overlapping spectra for the simultaneous identification of multiple 
antigens. 
Fluorescent and chemiluminescent labels were introduced and developed shortly after 
the breakthroughs with enzymes and are now commonly used in immunoassays due to the 
improved sensitivity of luminescence compared to spectrophotometric methods. Much like 
enzymes, fluorescent (e.g., fluoresceins, rhodamines, etc.) and chemiluminescent (e.g., 
luminol) labels are sensitive to their local environments and can be used to monitor the 
formation of the antibody-antigen complex without a separation step. These labels are also 
employed in solid phase immunoassays in which free label is washed away from the 
complexed label. The major shortcoming of fluorescence readout is interference from 
background signal from scattering and fluorescence of the sample, substrate, cuvette, or 
instrument hardware (i.e., lenses). Attempts to overcome this limitation with time-resolved 
fluorescence measurements and labels with long-lived fluorescence, such as lanthanide 
chelates, have proven successful. Like the products from enzyme labels, the emission 
spectra from many fluorophores is broad. However, since the fluorophore is immobilized on 
the solid phase rather than free to diffuse in solution like enzyme-substrate products, spatial 
addressing of multiple antibodies allows the use of a single fluorescent label in a multiplexed 
assay. In this case, the location identifies the antigen, with the fluorescence intensity then 
functioning in quantitation. The challenges with this approach lie both in the high throughput 
micro fabrication of many unique addresses and hardware to "read" each address. 
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Approaches to Improve Immunoassay Performance: Readout Techniques 
Immunoassays must be improved to meet the ever increasing demands for greater 
sensitivity, lower detection levels, greater speed, and higher throughput sought by diagnostic 
laboratories and bioterrorism prevention agencies. Advancements in readout technologies 
and development of methods to increase the rate of antibody-antigen binding are central to 
meeting these challenges. Numerous novel readout techniques have been reported in the 
literature recently, including surface plasmon resonance,37"42 quantum dots,43"51 
microcantilevers,52"54 and surface-enhanced Raman scattering.55"70 Each of these techniques 
is in its infancy but holds great potential for increasing throughput and improving sensitivity. 
Surface plasmon resonance (SPR) is a technique that detects refractive index changes 
at a metal substrate surface and methods have been developed to successfully apply SPR to 
immunoassay readout. SPR is a surface-sensitive, label-free method of monitoring and 
quantifying the complexation of an immobilized antibody with its target analyte. Moreover, 
this technique can be employed to follow the formation of such complexes in real-time. SPR 
measurements can be configured in three ways, scanning angle, scanning wavelength, and 
imaging, all of which require monitoring the intensity of reflected light on a metal/dielectric 
interface.37 Detectable limits of 10"9 to 10"13 M have been achieved with SPR readout, but the 
greatest benefits include real-time monitoring, increased throughput via imaging 
configurations, and reduced assay time with the elimination of a labeling step.38 However, 
SPR measurements can be compromised by fluctuations in refractive index that arise from 
uncontrolled temperature variations or mismatches in sample and buffer refractive indexes in 
flowing solutions, both of which can be misleading with respect to the association or 
dissociation of the antibody-antigen complex.71 
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Quantum dots (QDs) have also been explored as an alternative to traditional organic 
dye labels used in luminescence-based immunoassays.43"51 QDs are luminescent 
semiconductor nanocrystals, the most popular being zinc sulfide-capped cadmium selenide 
(CdSe-ZnS core-shell). QDs have been reported to have 20 times the intensity, 100 times the 
stability against photobleaching, and one-third the emission width of organic fluorophores 
such as rhodamine.51 These attributes make QDs very attractive as labels in immunoassays. 
As an example, ZnS-CdSe core-shell QDs have been utilized for the detection of the food 
born pathogen, Escherichia coli 0157:H7 (E. coli).so This assay resulted in a detectable 
range of 103 to 107 CFU/mL, 100 times better than the FITC fluorescence-based assay. The 
work of Hahn, et al., demonstrated the ultimate in sensitivity with the visualization of a 
single E. coli cell labeled with QDs.49 
Another attraction of QDs stems from the ability to fine tune their emission spectra by 
changing the particle sizes, facilitating the production of many unique labels. Coupled with 
the narrow emission band of a QD, multiplexed assays have proven successful.47 One of the 
challenges associated with the incorporation of QDs into assays is the lack of a universal 
method for coating QDs with protein.47 QDs have an inherent hydrophobic nature that is 
imparted by capping agents used during synthesis and limits biocompatibility. 
Hydrophobicity reversal is achieved via cap exchange or amphophilic encapsulation; 
however, issues related to stability against aggregation and reproducibility of QD-
biomolecule ratios have been encountered. Efforts are being made to develop a universal 
protocol for bioconjugation that address these issues.44"47 
Another promising label-free method of monitoring immunoreactions employs a 
functionalized microcantilever.52"54 In this type of assay, the antibody is immobilized on a 
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cantilever, and its oscillation frequency is monitored. The mass changes that results from 
antigen binding shifts the resonance frequency of the oscillating cantilever. The frequency 
shift is extremely sensitive to changes in mass and assay results have suggested that detection 
of a single baculovirus is possible.54 The label-free nature and real-time monitoring 
capability, in addition to its sensitivity, make this an appealing technology. Moreover, 
advances in microfabrication will facilitate multiplexed detection with an array of uniquely 
modified microcantilevers. However, before this method receives widespread recognition, 
limitations such as irreproducible biorecognition coatings and long-term drift of cantilever 
bending must be overcome.5 
Surface-enhanced Raman scattering, which is the subject of this dissertation, has 
recently been explored as a readout method for immunoassays on the basis of several 
intriguing attributes.55"70 First, in contrast to normal Raman spectroscopy, SERS intensities 
have been shown to be comparable to those of fluorescence. Unlike fluorescence, however, 
Raman bands are much narrower (less than one nanometer half widths), reducing the 
likelihood of spectral overlap from multiple labels and facilitating simultaneous detection in 
a multiplexed assay without the need for addressing. Optimum excitation is also dictated by 
the enhancing substrate rather than the scattering molecule; thus, only a single excitation 
source is needed for multi-analyte detection. Raman scattering is also unaffected by its 
surrounding environment (e.g., pH, ionic strength, quenchers) resulting in a more stable and 
reproducible signal. Finally, Raman scatterers are photostable due to the extremely short 
liftetime of the excited state. 
Several approaches have been taken to incorporate SERS into an immunoassay. The 
earliest work utilized a roughened silver capture antibody substrate to bind thyroid 
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stimulating hormone.60 In that work, the enhanced Raman signal of the label was monitored 
as a result of the enhancing substrate. Dou et al. developed an enzyme immunoassay in 
which the product of the enzyme-substrate reaction was Raman active.59 The product was 
then adsorbed onto colloidal silver for SERS readout. The work of Zhang et al. successfully 
developed a label-free immunoassay relying on SERS for readout.63 That work reported that 
the binding of calcium dipicolinate (CaDPA), a biomarker for bacillus spores, to a roughened 
silver substrate could be directly readout with the intrinsic scattering of CaDPA. 
Our research laboratory has developed a new SERS-based immunoassay in a 
sandwich-type format which employs extrinsic Raman labels (ERLs).56"58 ERLs are 
constructed by first coating a gold nanoparticle with a Raman reporter molecule. The gold 
colloid serves as an enhancing surface, while the Raman scatterer provides the signal for 
identification and quantification. Antibody is then covalently immobilized onto the modified 
nanoparticle to impart specificity. The resulting ERLs are used as tracers in a solid phase 
immunoassay. 
This design has been successfully applied to the simultaneous, multiplexed detection 
of IgG protein58 and the ultrasensitive detection of prostate specific antigen, a biomarker for 
prostate cancer.57 Chapter 2 details this type of assay and demonstrates the universality of 
this approach and its ultra high sensitivity in an assay for the detection of feline calicivirus. 
Approaches to Improve Immunoassay Performance: Increased Mass Transport 
Research has also focused on immunoassay time reduction, but at a lower level of 
activity with respect to the quest for improvements in sensitivity. However, the improvement 
on assay speed is yet another key facet in the creation of highly effective immunoassays. It 
has been repeatedly shown that antibody-antigen recognition is extremely fast, and that the 
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chief limitation arises from the mass transfer of antigen and/or label to the substrate.72"76 
Some experimental evidence for diffusion control of the immunoreaction include an 
observed: 1) decrease in the antibody-antigen binding rate with an increase in solution 
viscosity, 2) increase in the antibody-antigen binding rate with reaction mixture stirring, and 
3) decrease in the antibody-antigen binding rate for an immobilized antibody compared to 
that of a solvated antibody in free solution.72 These experimental findings have been 
supported by theoretical models describing solid phase immunoassay kinetics.73'74 
Drop application is the most common form of sample and label delivery to the 
sensing surface, and relies solely on diffusion for mass transport. This strategy translates into 
long assay times. Unfortunately, only a limited number of approaches have been explored to 
increase mass transport and capitalize on the rapid recognition rates of antibody-antigen 
coupling.77"83 Two of the more promising methods include electric-fi eld-driven assays77,78,82' 
and lateral-flow assays. " Electric-field driven assays take advantage of the charge on 
antigens and antibodies to attract them to a surface. The molecules can be manipulated 
electrophoretically through solution to specific locations in a microelectrode array78'82 or 
electroosmotically in microchannels.83 This method has been utilized to perform assays with 
1-min incubations steps; however, several parameters must be considered. For example, each 
molecule has a unique isoelectric point, and therefore a mobility that varies with pH. 
Moreover, transport will be influenced by the ionic strength of solution and size and shape of 
the microchanel. 
Lateral-flow, or immunochromatographic, assays have received a great deal of 
attention and have already been incorporated into many commercial systems.84"91 Lateral-
flow assays employ a porous membrane, typically nitrocellulose, as a solid phase with a 
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localized region of immbolized capture antibody. Capillary forces facilitate the flow of 
sample and label solutions through the membrane where the antigen and tracer are extracted 
and concentrated in the capture zone. This type of assay has been used to monitor drugs, 
toxins, hormones, proteins, and pathogens.86 The popularity of this "dip-stick" configuration 
lies in its ease of use, speed, and portability. Despite the widespread use of this technology in 
the health care industry, it suffers from certain inadequacies. First, these assays are only 
semi-quantitative and signal saturation is common. Additionally, most lateral-flow assays are 
limited to single analyte detection; tests for multiple antigens must be run serially with 
individual test strips, which can require large sample volumes. 
To overcome the mass transfer limitation of solid phase immunoassays and the 
weaknesses encountered by many of the newly developed methods to increase mass 
transport, Chapters 4 and 5 introduce rotation-induced flux. In these chapters, the capture 
substrate is controllably rotated to increase antigen and label flux to the capture surface, 
thereby reducing assay incubation times. 
Theoretical Origins of Surface-Enhanced Raman Scattering 
Raman spectroscopy is a vibrational spectroscopy involving the inelastic scattering of 
incident photons by a molecule. The incident photon induces an oscillating dipole in the 
molecule which acts as a source of scattered radiation. Most of the scattering occurs at the 
same frequency as the incident source and is termed Rayleigh scattering. However, a finite 
probability exists that the molecule will accept energy, equal to that of a vibronic transition to 
a higher energy state, resulting in scattered radiation that is shifted in frequency from the 
incident frequency. It is worth noting that not all vibrations are Raman-active; only a 
vibration that results in a nonzero change in polarizability at the equilibrium position of the 
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normal vibration is Raman active. Traditional Raman spectroscopy is inefficient and Raman 
intensities are only about 10"6 of the incident intensity. Even with extremely intense 
excitation sources (i.e., lasers) Raman spectroscopy is incapable of low-level detection for 
quantitative analysis. 
In 1974, Fleishman and co-workers observed unexpectedly high Raman signal for 
pyridine adsorbed onto anodized silver electrodes.93 At that time, this finding was attributed 
to a large number of adsorbates on the rough surface due to increased surface area. In 1977, 
work by Jeanmaire and Van Duyne94 and Creighton and Albrecht95 showed that observed 
intensities could not be explained by an increase in the number of adsorbates. This 
conclusion was the beginning of surface-enhanced Raman scattering (SERS). 
Several more experiments immediately followed revealing experimental parameters 
that impact enhancement and they have been summarized by Schatz.96 Key observations 
included the dependence of enhancement on surface preparation (i.e., roughness) and the 
dielectric property of the substrate (e.g., silver, gold, copper, etc.) while molecular identity 
was found to be less of a factor on enhancement. These experimental findings initiated 
several investigations into the theoretical underpinnings of the surface-enhancement 
mechanism.96"111 To fully exploit SERS in analytical chemistry, enhancement must be 
optimized and this will only be realized through a complete comprehension of the enhancing 
mechanism. 
While theoretical advances in the mechanistic underpinnings of SERS continue, there 
are still several shortfalls and conflicting models. It is, however, generally viewed that the 
enhancement arises from both electromagnetic and chemical interactions between the 
adsorbate and substrate. The chemical enhancement theory is perhaps more controversial, but 
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is believed to be due to a resonant charge-transfer state between the adsorbate and 
substrate.106'107'''' The electromagnetic theory, on the other hand, is consistent with the 
dependence of SERS on the roughness and dielectric properties of the substrate and attempts 
to explain enhancement due to changes in the localized field experienced by the adsorbate at 
the enhancing substrate surface. Of the two, the electromagnetic theory has been more 
thoroughly studied.96"105'108"110 Surface enhancement factors have been measured to be on the 
order of 106 to 108, with chemical enhancement responsible for factors of 10-100 and 
electromagnetic mechanisms contributing factors of 105 to 106. Because the electromagnetic 
mechanism is recognized as the most significant pathway for enhancement, the historical 
development of this theory is briefly presented. 
The intensity of Raman scattering is proportional to the square of the electric field 
experienced by the scattering molecule. There are two explanations for an enhanced local 
electric field on a conductive surface: 1) image charge effects99'112'113 and 2) excitation of 
surface plasmons.96'97'101'108'110 
Image field theory was first developed by King et al.112 and Efrima and Metiu113 to 
explain SERS dependencies on the excitation source, dielectric constant of the adsorbate and 
surface, electrode potential, scattering angle, and polarization. Qualitatively, the incident 
radiation induces a dipole oscillation, fj,jnd, in the adsorbate, which leads to an oscillating 
image dipole, |iijmage, in the conductive surface just below the adsorbate. The image dipole has 
an electric field associated with it, Ejmage, which adds constructively to Ejncjdent to increase the 
overall field felt by the adsorbate. This model is depicted in Figure 2. 
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Figure 2. Illustration of the induced dipole, n;nd, in an adsorbate and its image dipole, Ujmage, 
formed in the metal substrate. The hexagon represents the adsorbate and R is the separation 
distance between the adsorbate and the metal surface. 
A mathematical model for the image field theory was derived with the following 
assumptions: 1) the adsorbate is a point dipole, 2) dielectric constants are independent of the 
wavelength of Evident, 3) a sharp surface boundary of electron density exists, and 4) 
chemisorption effects are negligible. Given these conditions, the SERS enhancement factor 
[EF) can be calculated by Equation l " 
_5 0) EF = -
Wo 
' 4R3 
where G is a geometric factor based on incident angles and Fresnel coefficients, ao is the 
adsorbate polarizability, R is the adsorbate to image plane separation distance, and / i s given 
by Equation 2 
r = (eu+eA)eA 
(2) 
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where SM is the dielectric constant of the metal substrate and SA is the dielectric constant of 
the adsorbate. In general, G plays a rather insignificant role in determining the value of EF 
since its maximum value is 30 when the incident angle is optimized at ~60°. The value of/?, 
ceo, and the dielectric functions contribute much more to the magnitude of EF. While the 
parameter CCQ and the dielectric functions can be accurately estimated, the value of R is 
largely uncertain because of unknown adsorbate-metal complex geometry and unknown 
location of Ui„d within the molecule. Therefore, a wide range of enhancement factors have 
been calculated (10 -10 ) and this has led to conflicting views as to the contribution of the 
image field effect to the overall enhancement factor. 
The local field experienced by the molecule can be raised dramatically by excitation 
of the surface plasmons of the enhancing substrate. When the incident light is resonant with 
the plasmon frequency, conduction electrons collectively oscillate, increasing the 
polarizability of the surface and the localized field. The influence of the surface plasmon on 
SERS enhancement was first described by Moskovits.97 This initial rationalization has since 
been modified by Kerker et al,101 Gersten and Nitzan,102 Creighton,108 and Schatz.96 Of these 
works, the theoretical development by Schatz is the most advanced for an adsorbate on a 
metal spheroid and is briefly discussed below. 
The derivation for calculations of the localized electric field at a surface began by 
defining a simple model system, which consists of a single metal spheroid that is small 
compared to the wavelength of incident light and is coated with adsorbate molecules. 
Maxwell's equations were evaluated at the incident frequency, co, to calculate the electric 
field at the adsorbate at co, E(co). The electric field at the frequency of the Raman scattering 
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mode can also be calculated by similar treatment but evaluated at the scattered frequency, a'. 
Thus, the SERS enhancement factor is proportional to [E(o))]2[E(o)')]2. By assuming that the 
spheroid is small in comparison to the wavelength of incident light and by ignoring image 
charge effects, Maxwell's equations can be replaced by the LaPlace equation, which is more 
easily solved. 
Given these boundary conditions, and assuming an applied electric field EQ along the 
major axis of a spheroid, the mean-square electric field at the spheroid surface is given by 
Equation 3 
g* 0-*|P-fl +a(ofe!-?!) a«.)!<£-ofe2-?2)! (3) 
where ^is given by Equation 4 
C = 7 L J ^ (4) 
In this case, £{ is the dielectric constant inside the metal, £o is the dielectric constant outside 
the metal, and % varies from a value of 2 for a sphere to infinity for a rodlike surface asperity 
and is defined as 
1 
x
~
 + G , ( ^ o ) ( ^ - i ) ( 5 ) 
In Equations 3 and 5, & is given by 
£> = " l—-y (6) 
where 2a equals the minor axis and 2b is the major axis of the spheroid, and Qi is the 
Legendre function (Equation 7). 
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G.(£o)=(}&)n - 1 (7) 
The spherical coordinate, rj, in Equation 3 specifies location on the surface (e.g., rj = ±1 at the 
spheroid tips) and relates to the polar angle 9. 
fc-i) lX 7] = COS 9 
tf-cos29 (8) 
The electric field is greatest at the tips of the spheroid and has led to electromagnetic 
enhancement descriptions of the "lightning rod" effect.103 That theory is somewhat 
misleading, however, because it only represents enhancement of a single adsorbate at the tip 
rather than the average enhancement provided by the particle over all locations on the 
surface. This distinction is a particularly important point for systems in which the surface of 
the particle is fully coated with adsorbates. Schatz developed a modified form of Equation 3 
to consider the field over all rj and determine the average field at the surface and the average 
SERS enhancement factor (Equation 9).110 
(I*2M | l _ t f + 2 R C q - ^ + \c\2 0,(£o) 0(<fo )(£>-!) 
(£0 2-l)^+#0 2sin- ' 1 ^ 
v£>y 
(#- ! )>*+# sin"' ' O 
V=oy 
(9) 
The electric field at the surface in Equation 9 is maximized as C increases, or when 
Re(Ej+x£o) approaches zero and Im (e,-) is small. Assuming that e, can be described by the 
Drude expression, this situation occurs when the incident frequency matches the resonance 
frequency of the surface plasmon.96 It should be noted that the plasmon resonance for a 
sphere is often defined as the condition in which the real component of the complex 
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dielectric function is equal to -2 and the imaginary component is very small. This definition 
is consistent with that presented here given that ^ = 2 for a sphere and eo = 1 for air. 
A detailed analysis of these equations also suggests that the mean-square electric field 
is independent of the spheroid size for a fixed ratio of bla. However, it is known 
experimentally that particle size is a factor, and this discrepancy is an inadequacy of the 
theory. The dielectric property of very small particles changes due to surface scattering,114 
while induced dipoles in large particles suffer from radiation damping11S and dynamic 
depolarization effects.116 Schatz presents modifications to Equation 9 to correct for all of 
these effects. 
Surface scattering is a phenomenon which occurs when the particle size is smaller 
than the mean free path of the conduction electrons and electrons are scattered from the 
particle surface. As a consequence of surface scattering, the surface plasmon band broadens 
and damps out. The plasmon width can be quantifiably corrected by first invoking the Drude 
expression 
co((a + iy) 
where ^ is the bulk plasmon frequency and / i s the width of the plasmon resonance. For the 
case of a small particle, /consists of both bulk and surface contributions and is given by 
L
eff 
where u/is the Fermi velocity of the electrons and Z-^-is the effective average scattering 
distance which is dependent upon particle shape. Leffhas been previously expressed in its 
entirety,96 but reduces to Lejf= a = b for a sphere and Lejf= (16/3TC)<2 for b » a. For noble and 
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alkali metals, surface scattering significantly modifies £free, and therefore the mean-square 
electric field, for spheroids smaller than ~20 nm. 
For the case of a larger spheroid, radiation damping arises from secondary radiation 
from the induced dipole in the particle. The radiation emitted from different locations on the 
particle surface can also undergo destructive interference and is called dynamic 
depolarization. These effects can be quantified as a correction factor, D, that is used to 
rescale the induced dipole 
D = 1 
l-2/ifc3a„ -
b J 
(12) 
where 
(13) 
and c is the speed of light. The 1c1 term in Equation 12 corrects for radiation damping and the 
A2 term corrects for dynamic depolarization effects. For spheroids smaller than -1/10 of the 
wavelength of light, the dynamic depolarization term dominates while for larger particles 
radiation damping dominates; both effects cause the plasmon resonance to broaden and shift 
to longer wavelengths. 
By substituting Equations 10 and 12 into Equation 9, the average electric field 
experienced by an adsorbate on a metal nanoparticle can be accurately described. The 
advances over earlier models include consideration of the particle dielectric constant, average 
field over the entire surface of the particle, surface scattering, radiation damping and 
dynamic depolarization effects. 
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It is important to remember that largest SERS enhancement occurs when 
[E(CO)]2[E(G)')]2 maximizes. Thus, the electric field at both the incident frequency and 
scattered frequency must be considered. Therefore, maximum SERS enhancement is 
obtained when the surface plasmon resonance frequency optimally couples to both the 
incident (co) and scattered (co") frequencies. Collectively, theory and experiments have 
provided compelling evidence that this situation occurs when the surface plasmon resonance 
peak is midway between the excitation and scattered frequency, provided that the plasmon 
resonance is Lorentzian shaped.117"121 However, surface plasmon resonance may not be the 
only contributing factor to enhanced fields. High local fields in nanoparticle pores,118 near 
sharp edges, " between coupled particles, " and between coupled particles and 
substrates124,126'132"136 may contribute to surface enhancement in addition to the large fields 
provided by plasmon resonance. More studies are clearly necessary to further develop our 
understanding of the origin of SERS and this is the motivation for the work presented in 
Chapter 3. 
Surface Plasmon Resonance 
The previous section led to the important conclusion that the peak location of the 
surface plasmon resonance (SPR) of the enhancing substrate has a significant impact on the 
enhancement factor in a SERS experiment. Therefore, it is critical to understand the 
parameters influencing SPR so substrates can be designed and optimized for SERS 
enhancement through SPR manipulation. 
The simplest SPR model is developed for a single isolated particle.137 For particles 
smaller than the wavelength of incident light, all interactions are expected to be surface 
interactions and bulk properties are not observed. The electrons in these materials are then 
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free to travel throughout the material and are subject to the influence of an electromagnetic 
field. At a particular frequency, an incident electric field causes a collective oscillation of the 
electrons in resonance with the field frequency, resulting in a standing wave. This resonance 
frequency is dependent upon particle size, shape, and the dielectric functions of the particle 
and surrounding medium. A convenient method of measuring the resonant excitation of the 
plasmon oscillation is absorption and scattering spectroscopy.138 
Theoretical calculations of extinction spectra were first performed by Mie for 
spherical nanoparticles by solving Maxwell's equations and later developed to include 
ellipsoidal particles by Gan.137,139 Surface plasmon resonance can now be numerically 
calculated for any geometry using the discrete dipole approximation (DDA).122 In the DDA 
method, a particle of any shape is represented as JVpolarizable points in a cubic lattice. The 
induced polarization of each point (Pi) is given by 
P^a^EM (14) 
where a, is the polarizability of the ith element centered at rt and Eioc(ri) is the local electric 
field at position /. It is important to note that Eioc(ri) is the sum of the incident field and all 
other dipoles in the particle. The induced polarization of each individual element is then 
considered to determine the overall induced polarization of the entire particle. 
These models indicate that as particle size increases, the surface plasmon resonance is 
shifted to longer wavelengths. Calculations also reveal that as the spherical particle grows 
anisotropically to become rodlike, two SPR peaks are expected, one for traverse oscillation 
and the other for longitudinal oscillation. Moreover, an increase in the surrounding dielectric 
shifts the surface plasmon resonance to longer wavelengths. These models support the 
experimental findings. 
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The surface plasmon resonance is significantly shifted when two particles approach 
one another to within a few diameters.138 This effect represents a coupling of the induced 
dipoles in each particle. A similar approach to the DDA method has been developed to model 
the polarizability of a nanoparticle dimer or cluster.140 Like the DDA model, the polarization 
at a single point is calculated considering the incident electric field and the dipole fields of 
neighboring points. However, unlike the DDA model in which an individual particle is 
represented by several point dipoles, each point represents an individual particle in the 
aggregate. This model, consistent with experimental observations, reveals that coupling of 
particles results in a red shift and broadening of the SPR. This red shift in the SPR peak (i.e., 
color change) upon aggregation is the basis for many analytical applications, such as DNA 
hybridization-induced colloidal assembly.141 
The SPR of a nanoparticle is also significantly affected when brought into close 
proximity of a flat metallic substrate. Much like the particle-particle coupling, an image of 
the induced particle dipole (and multipoles) is produced in the underlying conductive 
substrate. The coupling of the image dipole with the nanoparticle dipole results in a shift of 
the SPR to longer wavelengths. The SPR of this system has been modeled by Okamoto and 
Yamaguchi142 using the polarizabilities tabulated with the methods of Aravind143 and 
Wind.144 This and related works have established experimentally and through modeling that 
the location of the SPR depends on the particle size, shape, spacing, and dielectric functions 
of the particle, underlying metal film, and ambient.130'136'142'145'I46 Understanding how 
variations in these parameters influence the SPR in this system is particularly important for 
optimization of a SERS-based analytical assay employing Raman-active nanoparticles as 
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labels for analyte bound to a gold substrate. SPR calculations, as well as a detailed 
experimental investigation into this system, are presented in Chapter 3. 
Models that underscore parameters influencing SPR, coupled with SERS theory that 
demonstrates the dependence of the enhancement factor on SPR, have led to a great deal of 
focus on developing SPR tunable substrates for optimized SERS measurements. Grating-type 
substrates147 and metal coated SiC>2 posts,148 as well as nanoparticle arrays fabricated via 
nanosphere121,131,146,149 and electron beam120'150 lithography have been utilized as SERS 
substrates. These fabrication techniques allow precise control over nanoparticle size, shape, 
and spacing, factors that can be used to manipulate the SPR. It is imperative that more 
research efforts, like those listed above and that presented in Chapter 3, be carried out to 
understand how to capitalize on the systematic control of SPR in order to increase SERS 
enhancement factors and to optimize the utility of a SERS-based analytical systems. 
Dissertation Overview 
Based on the themes introduced above, this dissertation describes the development, 
application, and optimization of a SERS-based solid phase immunoassay. Each of the 
following chapters is presented as individual manuscripts that investigate differing aspects of 
a SERS-based immunoassay, including universal application, surface enhancement origins, 
and assay time reduction. Chapter 2 begins with the extension of a previously developed 
concept for a SERS-based assay. Multiple buffers, ionic strengths, and concentrations were 
systematically studied to develop an immunoassay protocol that can be genetically applied to 
a wide range of analytes simply by swapping antibodies. This approach is demonstrated by 
the detection of feline calicivirus, the first virus detected utilizing this concept. The basis for 
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the surface enhancement mechanism in our assay is investigated in Chapter 3. In an effort to 
overcome mass transfer limitations that arise in solid phase immunoassays, the concept of a 
rotating capture substrate is introduced to increase solution flux to the sensor surface, thereby 
reducing assay times. The prospect of rotation-induced flux was first investigated utilizing 
label-free detection of porcine parvovirus with atomic force microscopy and the results of 
these studies are presented in Chapter 4. Chapter 5 describes the efforts to define a protocol 
for the combination of increased assay speed utilizing a rotating substrate with the ultra 
sensitivity offered by SERS-based detection. This dissertation is concluded with a summation 
of the insights gained through these works and a discussion of the future prospects of these 
technologies. 
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Abstract 
The need for rapid, highly sensitive, and versatile diagnostic tests for viral pathogens 
spans from human and veterinary medicine to bioterrorism prevention. As an approach to 
meet these demands, a diagnostic test employing monoclonal antibodies (mAbs) for the 
selective extraction of viral pathogens from a sample in a chip-scale, sandwich immunoassay 
format has been developed using surface-enhanced Raman scattering (SERS) as a readout 
method. The strengths of SERS-based detection include its inherent high sensitivity and 
facility for multiplexing. The capability of this approach is demonstrated by the capture of 
feline calicivirus (FCV) from cell culture media that is exposed to a gold substrate modified 
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with a covalently immobilized layer of anti-FCV mAbs. The surface-bound FCVs are 
subsequently coupled with an extrinsic Raman label (ERL) for identification and 
quantification. The ERLs consist of 60-nm gold nanoparticles coated first with a layer of 
Raman reporter molecules and then a layer of mAbs. The Raman reporter molecule is 
strategically designed to chemisorb as a thiolate adlayer on the gold nanoparticle, to provide 
a strong and unique spectral signature, and to covalently link a layer of mAbs to the gold 
nanoparticle. The last feature provides a means to selectivity tag substrate-bound FCV. This 
paper describes the development of the assay, which uses cell culture media as a sample 
matrix, and has a linear dynamic range of 1 x 10 to 2.5 x 10 viruses/mL and a limit of 
detection of 1 x 106 viruses/mL. These results reflect the findings from a detailed series of 
investigations on the effects of several experimental parameters (e.g., salt concentration, ERL 
binding buffer, and sample agitation), all of which were aimed at minimizing nonspecific 
binding and maximizing FCV binding efficiency. The performance of the assay is correlated 
with the number of captured FCV, determined by atomic force microscopy, as a means of 
method validation. 
Introduction 
The development of a versatile strategy for pathogen detection is central to human 
healthcare, veterinary medicine, and bioterrorism prevention.1 In the area of viral pathogen 
detection, the most used techniques include electron microscopy, fluorescent antibody 
labeling of frozen tissue sections (FATS), ELIS A, polymerase chain reaction (PCR), DNA 
hybridization, virus isolation, and serologic testing.2 These methodologies, however, often 
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lack the sensitivity, specificity, speed, cost, versatility, portability and/or throughput sought 
for such applications. 
At present, two avenues are being heavily explored to overcome these limitations. 
One approach relies on the recognition of nucleic acid motifs. Reports have detailed 
strategies to reduce the analysis time for viral detection by PCR,3'4 and to increase sample 
throughput by PCR multiplexing.5 The second approach, which has more historical 
precedence, utilizes the recognition of protein motifs. These assays take advantage of the 
documented specificity of antibody-antigen interactions, which facilitates method 
development and optimization. Several of these assays have also been coupled to novel 
readout technologies including immunoimaging atomic force microscopy (AFM),6 
immunosorbent scanning electron microscopy (SEM),7'8 fluorescence-based labeling9 and 
antibody-modified microcantilevers.10 These techniques have characteristics that address 
various weaknesses of the more conventional detection methods, including reductions in the 
limits of detection, which range from 105 viruses/mL for fluorescence9 and microcantilever 
detection10 to 108 viruses/mL for AFM detection.6 This report introduces a protein-based 
readout technique that has the potential to increase sample throughput, decrease readout time, 
enhance portability, and lower the limit for virus detection. 
One of the more recent readout techniques developed for immunoassays11"18 and 
DNA detection19"23 relies on surface-enhanced Raman scattering (SERS). As part of our 
interest in this area, Ni et al. exploited the attributes of SERS for the concurrent analysis of 
different IgGs. That work employed extrinsic Raman labels (ERLs). ERLs consist of gold 
nanoparticles that are modified with both an intrinsically strong Raman scatterer and an 
antibody. The former takes advantage of the well-established enhancement of scatterers when 
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coated on nanometer-sized gold particles,24 whereas the latter imparts the specificity for a 
target analyte. We have demonstrated the sensitivity of this type of immunoassay by the low 
level (~1 pg/mL) detection of prostate specific antigen (PSA) in spiked human serum 
samples,14 a limit of detection estimated to result from -60 binding events when using 30-nm 
diameter gold nanoparticles. We have also shown that optimizing the nanoparticle diameter 
with respect to laser excitation wavelength can lead to the facile detection of single-digit 
binding events in the absence of nonspecific adsorption.25'26 
The work herein extends our SERS-based immunoassay to the direct, low level 
detection of intact pathogenic viruses, using feline calicivirus (FCV) as a model target and 
cell growth media as a mimic of a biological sample matrix. To our knowledge, there has 
been only one study to date on the utilization of SERS for virus antigen detection;15 that 
work, however, detected only the capsid protein after it was detached from intact virus in a 
chip-based format that partially paralleled those in other reports.11"14,25 
FCV is a leading cause of upper respiratory infection in cats. FCV is a non-enveloped 
virus that has a capsid composed of 180 identical copies of a 76 kDa protein,27 and a 
hydrated radius of 36 nm. Moreover, FCV has strong morphological (size and shape) and 
genetic similarities to the human caliciviruses, noroviruses and saporviruses.29 However, 
FCV and the human caliciviruses are not antigenically cross-reactive. Human caliciviruses 
are commonly associated with viral gastroenteritis, are extremely contagious, and have been 
identified as potential bioterrorism agents.30'31 The human caliciviruses are particularly 
difficult to study due to their inability to grow in cell culture, while FCV is readily 
propagated in vitro.30'31 Thus, FCV also serves as a simulant for the human caliciviruses.32 
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Scheme 1 illustrates the steps in our viral immunoassay. Briefly, a monoclonal 
antibody specific for FCV (anti-FCV mAb) is immobilized via succinimidyl ester chemistry 
to a gold-bound thiolate adlayer formed from dithiobis(succinimidyl propionate) (DSP). 
When FCV is present, the immobilized layer of anti-FCV mAb (capture substrate) 
specifically extracts available virus. The substrate is then incubated with ERLs that bind to 
captured FCV. The ERLs consist of 60-nm gold particles modified by exposure to 5,5'-
dithiobis(succinimidyl-2-nitrobenzoate) (DSNB). The nitro group of the resulting thiolate 
adlayer provides an intense SERS signal, while the succinimide group acts as a coupling 
agent for tethering anti-FCV mAb to the nanoparticle. The quantity of FCV is determined by 
the spectral intensity of the symmetric nitro stretch (vs(N02)) of the DSNB-derived coating, 
which is also correlated with the number of captured FCV by imaging with atomic force 
microscopy as a means of method validation. The following sections describe the findings 
from this investigation, including details related to assay optimization and the ability of our 
SERS-based methodology to detect FCV in cell growth media at ~1 x 106 viruses/mL. 
Experimental 
Reagents. Gold nanoparticles [60 ran (<8% variation in diameter), 2.6 x 1010 
particles/mL] were purchased from Ted Pella. Octadecanethiol (ODT), sodium chloride, 
dithiobis(succinimidyl propionate) (DSP), phosphate buffered saline (PBS) packs (10 mM), 
bovine serum albumin (BSA) and Triton X-100 were received from Sigma. Poly(dimethyl 
siloxane) (PDMS) was obtained from Dow Corning. SuperBlock and borate buffer packs (50 
mM) were acquired from Pierce. 5,5'-dithiobis(succinimidyl-2-nitrobenzoate) (DSNB) was 
synthesized according to a recent literature procedure.14 
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Anti-FCV monoclonal antibodies (anti-FCV 2D10-1C4), purified via a protein G 
column (Pro-Chem) to 99.9% purity, were provided as 1 mg/mL stock solutions by National 
Animal Disease Center (NADC; Ames, IA). Aliquots of FCV (NADC strain), suspended in 
cell culture media (MEM media, CRFK cells), were also supplied by NADC. The FCV 
concentration of the stock solution (5.0 x 10 viruses/mL) is reported as the 50% tissue 
culture infective dose (TCID50), which was determined by the Reed-Muench method.33 All 
dilutions of this stock were made with cell culture media. 
Preparation of ERLs. ERLs are designed to: 1) provide a strong Raman signal; and 
2) demonstrate immuno-specificity.13'14,25 Furthermore, the colloidal suspension needs to be 
stable with respect to aggregation, and the suspending solution should be compatible with 
effective antigen-antibody binding. In earlier work,14'25 DSNB was synthesized to meet both 
attributes. Its symmetric nitro stretch has an intrinsically large Raman scattering cross 
section. Moreover, DSNB is bifunctional from a reactivity perspective. DSNB contains both 
a disulfide moiety, which chemisorbs as an adlayer of the corresponding thiolate to the 
surface of the gold nanoparticles, and a succinimidyl ester group, which couples to anti-FCV 
mAb via amide linkage.34"36 
Prior to modifying with DSNB, the pH of the nanoparticle solution was adjusted to 
8.5 by adding 40 JIL of 50 mM borate buffer to a 1.0-mL solution of gold nanoparticles. This 
pH: 1) is above the pi of the mAb, which inhibits aggregation of the labeled nanoparticles; 
and 2) deprotonates the amines of the mAb, which favors the formation of an amide linkage 
by reaction with the succinimidyl ester of DSNB. After pH adjustment, 10 i^L of 1 mM 
DSNB in acetonitrile were pipetted into the colloidal solution and mixed for 8 h. Next, 20 ^g 
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of anti-FCV mAb were added to the colloidal solution and allowed to react for 12 h. 
Flocculation tests indicated that this step effectively coated the suspended colloid.37'38 
The flocculation experiments, summarized by the extinction spectra in Figure 1, 
systematically varied the amount of anti-FCV mAb added to the colloidal solution and 
monitored aggregation upon the addition of NaCl. These experiments first pipetted 40 |aL of 
borate buffer into 1000 U.L of the as-received nanoparticle solution to adjust the pH to 8.5, 
followed by 100 \xL of anti-FCV mAb solutions with different amounts (5-50 |o.g) and 100 
uL of a concentrated NaCl solution to reach a final NaCl concentration of 150 mM (see 
below). At this point, the sample modified with 5 jag of anti-FCV mAb changed within a few 
minutes from a red to blue color, followed by the gradual appearance of a precipitate; all 
other samples appeared stable with respect to aggregation. After allowing all solutions to 
stand for 30 min, 200 uL of each solution were then diluted with 800 (J.L of deionized water 
in order to reduce the particle concentration for effective characterization by their extinction 
spectra. 
As shown in Figure 1, the as-received particle solution has a strong extinction 
maximum at 535 nm that is consistent with the location of the plasmon resonance of isolated 
gold particles with an average diameter of 60 nm.39 The loss of particles from the solution 
modified with 5 jig of anti-FCV mAb is further evident by the large decrease in the 
magnitude of the plasmon band, noting that the decrease in extinction solely from dilution 
should be only ~25%. The broadening and shift to longer wavelengths is also diagnostic of 
aggregate formation. The changes upon addition of larger quantities of anti-FCV are in 
reasonable agreement with expectations from dilution, and are an indication of stable 
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colloidal solutions. Moreover, there was no observable precipitate for samples stored for 
several weeks. All subsequent procedures therefore modified the particles by addition of 20 
p,g of mAbs in order to minimize consumption. 
To stabilize the ERLs and to block unreacted succinimidyl esters, the colloidal 
solution was modified by the addition of 10% BSA in 2 mM borate buffer (100 |iL) for 6 h. 
The suspension was then centrifuged at 2000g for 10 min to remove any excess DSNB, mAb 
and other residual materials. After decanting the clear supernatant, the loose red sediment 
was resuspended in 1.0 mL of 2 mM borate buffer containing 1% BSA. The 
centrifugation/resuspension cycle was repeated twice for thorough removal of excess 
reagents. The final volume of the resuspension buffer was varied to control the nanoparticle 
concentration, a step that included the addition of the appropriate volume of 1.5 M NaCl to 
yield a final NaCl concentration of 150 mM (see below). As a final step, the labeled 
nanoparticles were passed through a 0.22-um syringe filter (Costar) to remove any large 
aggregates. 
Capture Substrate Preparation. Template stripped gold (TSG)40 served as the 
capture substrate because its low roughness factor facilitated AFM imaging of the virus for 
protocol development and assay validation.41 TSG was prepared by resistively evaporating 
~250 nm of gold (99.9% purity) at a rate of 0.1 nm/s onto a 4-inch p-type silicon [111] wafer 
(University Wafer) with an Edwards 306A resistive evaporator. Glass microscope slides were 
cut into 1 x 1 cm squares and ultrasonically bathed in diluted Contrad 70 (Micro, Cole-
Parmer), deionized water, and ethanol, each for 30 min. The clean glass chips were affixed to 
the gold-coated wafer with 2-part epoxy (Epoxy Technology) and cured at 150 QC for 1.75 h. 
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The glass chips were then gently detached from the silicon wafer, which removes the 
sandwiched gold film, to yield a smooth gold surface on the topside of the glass chip. 
The TSG chips were exposed for -30 s to an ODT-soaked PDMS stamp with a 3-mm 
hole cut in its center, rinsed with ethanol, and dried under a stream of high purity nitrogen.42" 
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 The ODT-based adlayer formed a hydrophobic barrier for localizing reagents in a confined 
sample area, which minimized the consumption of antibody and virus solutions. The 
substrate was then submerged in a 0.1 raM ethanolic DSP solution for ~12 h, rinsed with 
ethanol, and dried under a stream of high purity nitrogen. This step formed a DSP-based 
adlayer at the center of the substrate, i.e., the area not inked by ODT in the stamping process. 
Anti-FCV mAb (20 \iL, 100 j^g/mL), diluted in 50 mM borate buffer (pH 8.5), was 
applied to the sample area for 8 h in a humidity chamber. This step forms a capture antibody 
layer by coupling through the terminal succinimidyl ester of the DSP-derived monolayer.34"36 
The substrate was rinsed by its immersion in three separate solutions of 10 mM PBS (2.25 
mL). Next, 20 uL of SuperBlock blocking buffer were pipetted onto the sample area and then 
rinsed with 10 mM PBS after a 12-h exposure. 
The capture substrate was exposed to 20 \xL aliquots of virus, diluted in cell culture 
media, for 8 h at room temperature in a humidity chamber and then rinsed with 2 mM borate 
buffer containing 1% BSA and 150 mM NaCl. The target FCV was captured directly from a 
freeze/thaw lysate of cultured cells. The captured viruses were then exposed to the labeled 
nanoparticles for -12 h at room temperature in a humidity chamber. These incubations were 
performed either with 20 \iL of labeled nanoparticles (5.2 x 1010 particles/mL) under stagnant 
conditions or with 1.0 mL of labeled nanoparticles (1.3 x 1010 particles/mL) in a 24-well 
plate on a shaker (New Brunswick) with agitation (90 rpm). The substrates were rinsed with 
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2 mM borate buffer (150 mM NaCl and 1% BSA) before drying with a stream of high purity 
nitrogen gas and measuring the SERS signal. 
Instrumentation, (i) SERS Measurements. The Raman spectra were collected with 
a NanoRaman I fiber-optic-based Raman system (Concurrent Analytical), a portable, field-
deployable instrument. The light source was a 30 mW, 632.8 nm He-Ne laser. The 
spectrograph consisted of an f/2.0 Czerny-Turner imaging spectrometer (6-8 cm"1 resolution) 
and a Kodak 040IE CCD thermoelectrically cooled to 0 °C. The incident laser light was 
focused to a 25-|_im spot size on the substrate at normal incidence using an objective with a 
numerical aperture of 0.68; the power at the sample was ~3 mW. The same objective was 
used to collect the scattered radiation. All spectra were acquired with a 1-s integration. 
(ii) Atomic Force Microscopy (AFM). Substrates containing captured viruses were 
imaged utilizing a MultiMode NanoScope Ilia SFM (Digital Instruments) equipped with a 
150-|xm scanner. The AFM was operated in TappingMode, imaging 5 x 5 |im areas at a scan 
rate of 1.5 Hz. The setpoint oscillation amplitude was set to 80% of the free oscillation 
amplitude. The cantilevers were n(+)-silicon TESP probes (Nanosensors) with a length of 
118 |im, a width of 27-29 urn, thickness of 3.6-4.5 jj.m, a spring constant of 32-70 N/m, and a 
resonant frequency of 327-421 kHz. The viruses in each image were enumerated manually. 
Results and Discussion 
Preliminary Findings. Initial attempts to detect FCV with SERS readout employing 
the labeling protocol developed in our immunoassay for PSA14 proved only marginally 
successful. AFM studies revealed that while the capture substrate effectively extracted a high 
number of FCV from spent culture media, the strength of the signal from the ERLs after 
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completing the labeling step was barely above background. There were two plausible origins 
for this observation. One, the ERLs failed to couple to the surface-bound FCV at a detectable 
level. Two, the composition of the solution employed in the ERL binding step (2 mM tris 
buffer, pH 7.6) triggered the loss of captured FCV by degrading the antigen-antibody 
interaction. 
As a consequence, we re-examined the preparation of the ERLs and the solutions 
employed in several of the assay steps in an effort to both optimize the labeling step in the 
immunoassay and to minimize nonspecific ERL binding. Based on our earlier experiences in 
using ERLs,13'14'25 four factors were manipulated and tested: ionic strength of the rinsing 
buffers and ERL solution, binding buffer of the ERLs, blocking buffer, and surfactant 
additives in the ERL solution. The following sections present the key results from the 
optimization investigations, including ionic strength, binding buffer, and agitation, while the 
evaluation of blocking agents and surfactants are summarized in the supporting information. 
The final section details the performance and validation of the optimized assay, and briefly 
draws comparisons to other assay formats. 
Effect of Ionic Strength. AFM-based characterizations of the capture substrate after 
FCV binding, which will also be employed in a subsequent section for assay validation, 
revealed that the stability of the virus-antibody complex was sensitive to the composition of 
the solutions used in the rinse steps. Studies, for example, indicated that prolonged exposure 
to deionized water led to a dramatic reduction in the number of captured viruses. These 
findings suggested that the low responses in the initial assay attempts reflect a disruption of 
the virus-antibody interaction in low ionic strength media and the subsequent loss of FCV 
from the capture substrate. While reasonable to suspect the need for a high ionic strength 
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labeling solution because the antibodies are grown under physiological conditions (i.e., 150 
mM NaCl), our work with PSA did not exhibit a strong sensitivity to ionic strength. 
The influence of ionic strength on the amount of captured FCV is shown by the AFM 
images (5x5 um) in Figure 2. These samples were prepared by exposing the capture 
substrates to 20 |iL of stock FCV solution (5.0 x 108 viruses/mL). The substrates were then: 
1) soaked for -12 h in 2 mM borate buffer (pH 8.5) of varied NaCl concentration (1 to 150 
mM); 2) rinsed with the same soaking solution; 3) gently and quickly rinsed with deionized 
water and 4) imaged with AFM. As is evident, the images reveal the presence of 
nanometrically-sized objects that have a surface concentration affected by ionic strength. 
These objects have a size and shape consistent with the footprint for FCV after drying, which 
yields particles of ~22 nm in diameter. Smaller, irregularly sized objects are also detected 
and are ascribed to cell debris and other components in the spent cell culture medium. The 
presence of captured FCV is supported by a more exacting analysis of the AFM data, which 
is presented later when validating the SERS-based assay. 
The dependence on ionic strength, plotted as the number of captured viruses in a 25-
|am2 image against NaCl concentration (see supporting information) reveals that the number 
of FCVs bound to the substrate plateaus at ~1000 viruses/25 nm2 when the salt concentration 
reaches ~10 mM. In contrast, lower ionic strength solutions resulted in fewer bound viruses. 
This result supports the hypothesis that the composition of the ERL solution (2 mM 
tris) led to the loss of captured FCV in the preliminary experiments. However, the ERLs 
prepared using our earlier procedures rapidly aggregated upon the addition of 150 mM NaCl. 
As a consequence, we next focused on determinations of the conditions necessary to stabilize 
the ERLs in high ionic strength solution, with the goal to enable usage of ERLs suspended in 
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buffers containing 150 mM NaCl in order to match physiological conditions. Systematic 
studies of nanoparticle centrifugation rate, mAb concentration added to the nanoparticles, the 
addition of BSA to the nanoparticles, and the pH at which the mAbs coat the nanoparticles 
led to successful preparation of non-aggregated ERLs in 150 mM NaCl. The results of these 
studies indicated that using optimum conditions, including a centrifugation rate of 2000g, 
mAb concentration of 20 ug, BSA concentration of 1%, and pH of 8.5 for mAb adsorption, 
the ERLs are stable in 150 mM NaCl. 
Optimization of ERL Binding Buffer. The next series of experiments examined the 
effect of the pH of the ERL binding buffer. These experiments reflected possible differences 
in labeling effectiveness by recognizing that the pH of the borate buffer is alkaline of that 
used in many immunoassays, which are often designed to closely match physiological 
conditions. However, ERLs suspended in borate buffer (pH 8.5) were stable in high ionic 
strength solutions for several weeks, whereas aggregation in phosphate buffer became 
apparent within -24 h after the final resuspension step. Similar to the flocculation study in 
Figure 1, the instability became apparent first by a gradual change in the color of the 
suspension from red to blue, followed by the appearance of a precipitate and a marked 
decrease in the extinction at 540 nm. Moreover, a series of flocculation studies indicated that 
it was the pH and not the identity of the buffer that dictated the stability of the ERLs. 
Nevertheless, the short-term stability of ERLs in phosphate buffer permitted tests of the 
influence of pH in the labeling step. 
Figure 3 shows the SERS spectra comparing the effect of borate buffer (pH 8.5) to 
PBS (pH 7.4), both containing 150 mM NaCl and 1% BSA. First, two capture substrates 
were exposed to a 2.5 x 10 viruses/mL solution of FCV. After rinsing, one sample was 
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treated with the borate-buffered ERLs and the other was dosed with the PBS-buffered ERLs. 
Two more substrates, serving as controls, were exposed to blank cell culture media before 
treatment with one of the two buffered solutions of ERLs. 
The SERS spectra reveal the presence of the ERLs, and have features (e.g., the 
symmetric nitro stretch, 14CNO2), at 1336 cm"1 and an aromatic ring mode at 1558 cm"1) 
consistent with the DSNB-derived adlayer. Furthermore, comparisons of the v^(N02)-
intensities yield two additional conclusions. First, the intensity for the samples exposed to 
FCV (Figure 3A) is nearly three times larger when treated with ERLs in borate buffer 
compared to those incubated with ERLs in PBS. Second, the intensity of the control (Figure 
3B) in PBS is nearly twice that in borate buffer. The borate buffer is therefore more effective 
at promoting the binding of the ERLs to captured FCV and at minimizing the extent of 
nonspecific ERL adsorption, potentially translating to a sixfold improvement in the detection 
limit. We suspect that the pH of PBS is close to the pi of anti-FCV mAb, which would lead 
to particle aggregation and a larger background signal for the blank. The remainder of these 
investigations therefore employed the borate buffer. 
Effect of Agitation. The last of the key optimization efforts explored the utility of 
agitating the ERL solution during its incubation with the substrate. Agitation should lower 
the tendency of ERLs to settle out on the substrate, which would increase the probability of 
nonspecific binding. For effective agitation, the volume of the ERL solutions was increased 
to 1.0 mL and the entire substrate was submerged in the resulting suspension. 
To this end, the capture substrates were first exposed to either FCV solutions (2.5 x 
108 viruses/mL) or blank culture media. The substrates were then rinsed and incubated with 
1.0-mL solutions of ERLs on a rotary shaker (90 rpm). Importantly, results showed that the 
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intensity of the v,(N02) for the FCV-treated substrates was 23000-25000 cts/s, which is 
similar to that when performing the assay with 20 f^ L of ERLs under static conditions. The 
value of agitation becomes evident, however, when examining the signals for the blank 
samples. The signal from the blank samples is only 525-570 cts/s with agitation, while under 
static conditions the intensities ranged from 2000 to 5000 cts/s. These results suggest a 
fourfold to tenfold improvement in the detection limit with the addition of agitation. 
SERS-Based Immunoassay of FCV. The results from the optimization studies were 
employed to design an effective procedure for an immunoassay for FCV. Capture substrates 
coated with anti-FCV mAbs were incubated with FCV solutions that were diluted in cell 
culture media to concentrations ranging from 5.0 x 105 to 2.5 x 108 viruses/mL. 
Representative SERS spectra for each FCV concentration, collected with a 1-s integration 
time, are shown in Figure 4. We have also carried out a parallel AFM investigation as a 
means to cross-correlate the SERS responses with the number of captured viruses. A portion 
of the AFM results are shown in Figure 5. These results, however, are only for captured 
viruses; this reflects difficulties in reliably imaging virus-bound ERLs after rinsing 
thoroughly with water to remove the residue that remained when drying samples rinsed with 
solutions containing a high salt content.45 
The SERS results in Figure 4 show an increase in the response of the spectral features 
diagnostic of the ERLs as FCV levels increase. The spectrum for the blank indicates the 
presence of a small but readily detectable level of nonspecific ERL binding. These responses 
also qualitatively follow the evolution of the AFM images in Figure 5 in that the number of 
captured viruses increase as the concentration of FCV increases. Moreover, the cross-
sectional plot confirms the capture of FCV, which has a size of ~22 nm after extensive 
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drying. We note that the differences between the size of the viruses based on its height with 
respect to its lateral dimension arise from tip convolution effects which can distort the lateral 
dimension of an imaged object.46 
Figure 6 summarizes both sets of characterizations in the form of dose-response 
curves. The SERS data plots the Vs(NC>2) intensity. In this plot, each data point is the average 
signal of five measurements from different locations on the same substrate and the standard 
deviations are represented by the error bars. The plot is linear over approximately three 
orders of magnitude. Though not shown, the response plateaus at a virus concentration of 2.5 
x 108 viruses/mL. The limit of detection, defined as the concentration of FCV that yields a 
response equal to the blank signal plus three times the standard deviation of the blank, was 
determined to be 1 x 106 viruses/mL. 
Finally, a comparison of the two different plots in Figure 6 provides a basis for 
validation of the SERS data. As is evident, the number of captured FCV, which was 
extrapolated from 25 urn2 images to 500 (am2 to approximate the area sampled in the SERS 
experiments, also undergoes a linear increase with concentration. The correlation between 
the two plots shows that for every captured virus, the SERS response is ~3 counts/s. The 
noise in the blank measured by SERS is 70 counts/s; therefore a signal of 210 counts/s above 
background is defined as the limit of detection. The correlation between the SERS signal and 
AFM data suggest that SERS signal at the limit of detection arises from the presence of ~70 
captured viruses. In other words, we have the capability of detecting less than one hundred 
binding events, which is of immense value to the ultra-low level detection of viral pathogens 
and many other immunodiagnostic areas. 
54 
Conclusions 
This report is the first demonstration of the low level detection of an intact viral 
pathogen in a sandwich immunoassay format based on a SERS readout method. This method, 
resulting in a limit of detection of 106 viruses/mL, is therefore competitive with other 
methods viral assays, such as fluorescence and microcantilevers, which have limits between 
105 and 108 viruses/mL. Moreover, a SERS-based readout has greater facility in multiplexing 
for multi-virus detection. However, to fully realize this potential, approaches (e.g., operation 
at physiological temperatures47 and modes to increase mass transfer48) are needed in order to 
reduce the time for both incubation steps. Experiments to this end are planned. We are also 
beginning to further investigate details related to the enhancement mechanism with respect to 
the possible plasmon coupling of the ERLs with the underlying gold substrate, along with the 
use of in situ AFM imaging to quantify the binding stoichiometry between the ERLs and 
captured viruses. 
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Figure Captions 
Figure 1. UV-visible extinction spectra of colloidal gold (60 nm) before and after mixing 
with anti-FCV mAb (5-50 \ig) for 1 h, followed by exposure to 150 mM NaCl. 
Figure 2. AFM micrographs (5x5 fim) of FCV bound to an anti-FCV mAb capture 
substrate. These images were obtained after a 12-h exposure of capture substrates to a 5 x 108 
viruses/mL solution in cell culture media and subsequent soaking for ~12 h in 2 mM borate 
buffer that also contained (A) 1, (B) 5, (C) 10, or (D) 150 mM NaCl. 
Figure 3. SERS spectra for substrates labeled with ERLs suspended in borate buffer and 
o 
phosphate buffer: (A) 2.5 x 10 viruses/mL in cell culture media and (B) blanks (i.e., cell 
culture media only) exposed to labeled nanoparticles in 2 mM borate buffer (pH 8.5) or 10 
mM phosphate buffer (pH 7.4). Both buffers contained 150 mM NaCl and 1% BSA. 
Figure 4. Results from the SERS-based immunoassay detection of FCV. SERS spectra (1-s 
integration) measured for various FCV concentrations: a) blank (cell culture media only), b) 
5.0 x 105, c) 5.0 x 106, d) 5.0 x 107, e) 1.0 x 108, f) 2.5 x 108 viruses/mL. The spectra are 
offset for visualization. 
Figure 5. AFM micrographs ( 5 x 5 fim) of FCV bound to capture substrates at three 
different concentrations. The images represent the number of FCV bound after exposure to a 
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virus solution of (A) 3 x 108, (B) 5 x 107, (C) 0 viruses/mL (blank cell culture media) (D) 
cross-sectional plot of line shown in (A). 
Figure 6. Dose-response curves for SERS-based (circles) and AFM-based (squares) 
detection of FCV in cell culture media. The SERS calibration curve is constructed with the 
intensity of the nitro band at 1336 cm"1. The SERS assays were run on duplicate samples, 
with each data point representing the average signal for five measurements from different 
locations on the same sample. Each AFM data point is the average number of FCV bound 
from five samples with five images per sample; the error is smaller than the data point. 
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Supporting Information 
Effect of Ionic Strength. The dependence on ionic strength is detailed further in 
Figure S-l, which plots the number of captured viruses in a 25-|am2 image against NaCl 
concentration. Figure S-l reveals that the number of FCVs bound to the substrate plateaus at 
-1000 viruses/25 urn2 when the salt concentration reaches ~10 mM. No significant 
differences in the number of captured viruses were found using higher salt concentrations. In 
contrast, lower ionic strength solutions resulted in fewer bound viruses. 
Evaluation of Blocking Agents. In an effort to minimze the covalent attachment of 
the labeling antibody on the ERL to any unreacted succinimidyl esters remaining after 
capture antibody immobilization, three commonly used blocking agents were tested as 
"capping" additives: SuperBlock, StartingBlock and 1% BSA in 50 mM borate buffer (pH 
8.5). SuperBlock and StartingBlock have a pH of 7.4. For this evaluation, different capture 
substrates were incubated with 20 [iL of one of the blocking buffers, followed by exposures 
to cell culture media (without FCV) and to ERLs. Figure S-2 shows the spectroscopic results 
of this experiment. The blank signal was the lowest using SuperBlock and the largest using 
StartingBlock. 
The same set of tests was carried out with the ERLs. The use of both SuperBlock and 
StartingBlock resulted in the irreversible aggregation of the ERLs, which is ascribed to the 
pH-induced instability found when attempting to suspend the particles in phosphate buffer. 
As a result, the ERLs were blocked with the 1% BSA solution, whereas the capture 
substrates were treated with SuperBlock. 
69 
Effect of Triton X-100 and Other Surfactants. The surfactants Triton X-100, 
Tween 20, and Tween 80 were also added to the ERL suspension in an effort to limit 
nonspecific binding between the mAbs of the capture substrate and ERLs. A portion of these 
results is presented by the SERS spectra in Figure S-3. Capture substrates were exposed to 
either a 2.5 x 108 viruses/mL solution of FCV or to blank cell culture media. The samples 
were then incubated with 20 uL of ERLs in 2 mM borate buffer (1% BSA, 150 mM NaCl) 
with or without 0.1% Triton X-100. Interestingly, while showing a clear difference in 
backgrounds, the strength of the SERS signal from the blank was marginally affected by the 
presence of Triton X-100, as shown in Figure S-3 A. Figure S-3B, however, reveals that the 
ERL intensity was significantly lower for samples with captured viruses when Triton X-100 
was used. This difference is ascribed to the affect of the surfactant on the capsid of the virus. 
The capsid of FCV is composed of 180 identical proteins that act as the selective recognition 
sites for mAb coupling. We believe that the surfactant disrupts the structure of the capsid, 
effectively denaturing the tertiary structure of the binding sites on the virus. 
Other surfactants, such as Tween 20 and Tween 80, were also examined. In these 
cases, unfortunately, the addition of the surfactant lowered the surface tension of the ERL 
solution to a level sufficient to completely wet both the mAb capture address and the ODT 
confinement layer used for droplet localization. This spreading lead to an unacceptable 
degradation in the reproducibility of the assay and no further tests with surfactants were 
conducted. 
Effect of Agitation and Optimization of Nanoparticle Concentration. For 
effective agitation, the volume of the ERL solutions was increased to 1.0 mL and the entire 
substrate was submerged in the resulting suspension. The disadvantage of using a large 
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volume of nanoparticles is the increase in reagent consumption. Therefore, several dilutions 
of labeled nanoparticles were tested to determine the minimum concentration of 
nanoparticles necessary to saturate the captured FCV. 
To this end, the capture substrates were first exposed to either FCV solutions (2.5 x 
108 viruses/mL) or blank culture media. The substrates were then rinsed and incubated with 
1.0-mL solutions of ERLs at varying concentrations (1.04 x 109 to 2.6 x 1010 ERLs/mL) on a 
rotary shaker (90 rpm). Figure S-4 plots the results from two trials; the error bars represent 
the standard deviation of the signal obtained from different locations on the same sample. 
Although exhibiting small differences between the two trials, the intensity of the ^(NC^) for 
the FCV-treated substrates undergoes a gradual increase with increasing ERL concentration. 
The response reaches a maximum at ~1.3 x 1010 ERLs/mL, which corresponds to 23000-
25000 cts/s. Importantly, the signal from the blank samples is much lower than that of the 
FCV-treated samples, reaching a maximum of only 525-570 cts/s at a concentration of 1.3 x 
1010 ERLs/mL. 
In comparison, the typical signal obtained under static conditions for FCV samples 
(2.5 x 108 viruses/mL) when performing the assay with 20 uL of ERLs (5.2 x 1010 ERLs/mL) 
is also -25000 cts/s. This response is similar to that obtained with a larger volume (1.0 mL) 
of diluted nanoparticles (1.3 x 1010 ERLs/mL) with agitation. The value of agitation becomes 
evident, however, when examining the signals for the blank samples under static conditions, 
which ranged from 2000 to 5000 cts/s. Agitation therefore resulted in a significant decrease 
in the response from nonspecific binding. Agitation also improved the reproducibility of 
replicate assays. Since the blank signal showed only a weak dependence on ERL 
concentration, the overall reduction in the background is a direct consequence of sample 
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agitation. 
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Supporting Figure Captions 
Figure S-l. Dependence of the number of captured FCV on NaCl concentration. The data 
were obtained by imaging 5 x 5 fxm areas of samples after exposure to 2 mM borate buffer 
and varied concentrations of NaCl for -12 h. Each data point represents the average FCV 
density from five images and the error bars represent the standard deviations. 
Figure S-2. SERS spectra demonstrating the influence of blocking buffer on the SERS 
response from the nonspecific binding of nanoparticles to blank substrates. 
Figure S-3. SERS spectra demonstrating the influence of Triton X-100 on the binding of the 
ERLs to the capture substrates. (A) Blanks and (B) 2.5 x 108 viruses/mL exposed to ERLs in 
2 mM borate buffer that contained 150 mM NaCl or 150 mM NaCl and 0.1% Triton X-100. 
Figure S-4. SERS intensities of v.s(N02) as a function of ERL concentration. The samples 
were exposed to 1.0 mL of ERLs under agitation. The results form two trials are plotted and 
the error bars represent the standard deviation of the signal obtained from different locations 
on the same sample. 
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Abstract 
This paper systematically investigates the influence of an underlying metallic 
substrate (i.e., gold and silver) on the surface plasmon resonance (SPR) of labeled gold 
nanoparticles, from both experimental and theoretical perspectives, and the concomitant 
impact on the surface-enhanced Raman scattering (SERS) signal from the labels. These 
experiments employ nanoparticles of varied sizes (30-100 nm) that are coated with a 
bifunctional Raman scatterer composed of: 1) a disulfide for chemisorption to the 
nanoparticle surface; 2) a succinimidyl ester for formation of a covalent linkage to an amine-
terminated self-assembled monolayer on the underlying substrate; and 3) an aryl nitro group 
with an intrinsically strong Raman active vibrational mode. This approach allows facile 
systematic assessments of how variations in nanoparticle size, substrate composition, and the 
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gap between the nanoparticle and substrate affect the SPR of the bound particles. Both UV-
VIS transmission and reflection absorption (incident angle of 58°) spectroscopy are used to 
characterize the effect of each of these parameters on SPR. These results are then correlated 
with SERS enhancement factors that were determined by accounting for particle surface 
concentrations, which were measured by atomic force microscopy, and the absolute number 
of labels, which were calculated based on the surface area of each of the different-sized 
particles. All SERS spectra were collected at an incident angle of 58° with respect to the 
surface normal. As expected, the SPR for particles in solution red shifts with increasing 
particle size. More importantly, the SPR moves to even longer wavelengths as the size of 
immobilized particles increases, and as the gap between the immobilized particle and 
substrate decreases. The red shift is also greater for a gold nanoparticle tethered to a gold 
substrate compared to a silver substrate. A theoretical model for the extinction of a particle 
above a flat substrate, corrected for surface scattering, radiation damping, and dynamic 
depolarization is also briefly detailed. SPR results calculated with the model are consistent 
with the shifts observed in the SPR position for each of the manipulated experimental 
variables. The largest SERS enhancement factors are found for samples with an SPR 
maximum (X.maX) between the wavelengths for laser excitation (633nm) and the Raman band 
for the symmetric nitro stretch of the particle coating (690 nm). As an example, an order of 
magnitude in the SERS enhancement factor is gained for a 60-nm particle immobilized 1.2 
nm above a gold substrate (SPR A™ax = 657 nm) compared to that for a 30-nm particle (SPR 
m^ax = 596 nm). 
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Introduction 
Surface modified gold nanoparticles have recently been developed to function as 
analytical reagents in ultra sensitive bioassays based on surface enhanced Raman scattering 
(SERS).1"15 In our laboratory, antigens captured by antibody-modified gold surfaces are 
detected using Raman reporter-labeled gold nanoparticles. These particles, which we have 
termed extrinsic Raman labels (ERLs), are prepared by the sequential immobilization of an 
intrinsically strong Raman scatterer, followed by that of a molecular recognition moiety (i.e., 
antibody). ERLs with 30-nm diameter gold particles were originally employed. ' However, 
we have recently shown that larger diameter particles (e.g., 60 nm) lead to lower limits of 
detection.12'13 In view of the widespread interest in this assay strategy,1"15 it is of 
fundamental and technological importance to gain insights into the mechanism that leads to 
this observation. 
Although not fully understood at a quantitatively predictable level, the majority of the 
enhancement in SERS originates from large local electric fields at surfaces with nanometer-
sized asperities that arise from excitation of surface plasmons.16 Many studies have therefore 
focused on the development of theories that can be used in conjunction with experimental 
techniques that manipulate the surface plasmon resonance (SPR) at roughened substrates in 
order to determine the underpinning relationships between SPR and SERS.17"26 The 
combined weight of these efforts has firmly established that the location of the SPR depends 
on the size, shape, spacing, and composition of the nanometric features, as well as the 
dielectric properties of the surrounding medium.27"30 
As noted, a great deal of effort has been placed on the development of substrates that 
allow facile manipulation of the parameters that influence SPR in order to develop and refine 
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our understanding of the relationship between SPR and SERS. Early work was performed 
with colloids,17'18 island films,19'20 grating-type substrates,21 and metal coated SiC>2 posts.22 
More recently, nanoparticle arrays fabricated with nanosphere lithography23,24'28'31 and 
electron beam lithography25'26 have been utilized. These approaches, to varying degrees, 
have been applied to probe the theoretical links between SPR and SERS. This work has 
shown that the coupling of the localized fields between nanostructures not only results in an 
amplified field between the asperities, but also shifts the localized surface plasmon resonance 
to longer wavelengths, both of which have a profound influence on the SERS enhancement 
factor.31"38 
The conduction electrons in bulk smooth metal films can also be excited to generate 
propagating electromagnetic waves at the surface called surface plasmon polaritons. Much 
like the interparticle interactions, surface plasmon polaritons can couple to the surface 
plasmons of nearby nanoparticles, shifting and enhancing the resulting electromagnetic 
field.33'39_44 Theoretical treatments indicate that the SPR for such systems will be strongly 
dependent on nanoparticle-substrate spacing and substrate composition, in addition to 
nanoparticle size, shape, composition, and dielectric constant of the ambient.45-47 At present, 
however, there is limited experimental evidence to directly support these predictions.47 
This paper introduces and applies a model system for the experimental investigation 
of the influence of the dielectric properties of the underlying substrate and spacing between 
the nanoparticle and substrate on the SPR of the nanoparticle. We then examine these 
findings within the context of extended theoretical treatments,46'47 which consider the effects 
of surface scattering, radiation damping, and dynamic depolarization. To this end, gold 
nanoparticles labeled with a bifunctional Raman-active self-assembled monolayer are 
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captured using a functionalized self-assembled monolayer on a gold or silver substrate. The 
monolayer on the substrate acts as a coupling agent and as a spacer to control the gap 
between the particle and substrate. This methodology therefore enables a systematic 
assessment and comparisons to theoretical predictions of the impact of particle size, the 
separation between the substrate and particle, and the composition of the substrate on SPR by 
using UV-VIS reflection spectroscopy. These results are then correlated with measured 
SERS enhancement factors that were evaluated considering particle surface concentrations, 
determined using atomic force microscopy (AFM), and the number of scatterers, 
approximated by the particle surface area. This paper concludes with a discussion of the 
relationship between the wavelength of the SPR maximum and SERS enhancement factor 
and its implication for designing an optimized SERS-based analytical assay. 
Experimental 
Reagents. Gold colloids with nominal diameters of 30 (2.0 x 1011 particles/mL), 50 
(4.5 x 1010 particles/mL), 60 (2.6 x 1010 particles/mL), 80 (1.1 x 1010 particles/mL), and 100 
nm (5.6 x 109 particles/mL) were purchased from Ted Pella. The vendor-specified dispersity 
of the particle size was less than 8%. N-hydroxysuccinimide (NHS), 1,3-
dicyclohexylcarbodiimide (DCCD), 5,5'-dithiobis(2-nitrobenzoic acid) (DNBA), Triton X-
100, and 2-aminoethanethiol hydrochloride (AET) were obtained from Aldrich. 11-Amino-1-
undecanethiol hydrochloride (AUT) was acquired from Dojindo Laboratories. Borate buffer 
packs (50 mM) were purchased from Pierce Biotechnology, and diluted as needed. The 
synthesis of 5,5'-dithiobis(succinimidyl-2-nitrobenzoate) (DSNB) is described elsewhere.7 
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Preparation of Substrates. Template-stripped gold and template-stripped silver were 
used as substrates because their low roughness factors facilitated enumeration of particle 
surface concentration by AFM. These substrates were prepared by the resistive evaporation 
of-300 nm of gold (99.9% purity) or silver (99.9% purity) onto a 4-in p-type silicon [111] 
wafer (University Wafer) at a rate of 0.1 nm/s with an Edwards 3 06A metal evaporator. 
Glass microscope slides were cut into ~1 x 2 cm chips and cleaned by sonicating in dilute 
surfactant solution (Micro, Cole-Parmer), deionized water, and ethanol, each for 30 min. The 
clean glass chips were bonded to the gold- or silver-coated silicon wafer using two-part 
epoxy immediately upon removal from the evaporator. The epoxy was then cured at 150°C 
for 2 h and allowed to cool. The glass chips were then carefully detached from the silicon 
wafer, exposing a smooth (RMS roughness ~0.6 nm) gold or silver surface. 
Monolayers were formed by immersing a gold or silver substrate in a 1.0 mM 
AET or AUT ethanolic solution for 8-12 h. The substrates were then removed from the thiol 
solution, rinsed with ethanol, and dried with a stream of high purity nitrogen. 
Preparation of Raman Reporter-Labeled Gold Nanoparticles. DSNB was used as 
the Raman reporter molecule due to the large intrinsic Raman scattering cross-section of its 
symmetric NO2 stretch and its bifunctional reactivity. DSNB forms a thiolate coating on the 
gold nanoparticles through cleavage of its disulfide moiety, while its succinimidyl ester 
functional group can react with primary amines to form an amide linkage. The bifunctionality 
is of particular importance for immobilizing the nanoparticles to amine-modified substrates. 
Each set of particles was modified by a multi-step procedure. First, 1.0 mL of gold 
colloid solution was centrifuged at 2000g for 10 min, the supernatant discarded, and the 
nanoparticles resuspended in 1.0 mL of 2 mM borate buffer (pH 8.5) containing 0.1% Triton 
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X-100. Following resuspension, 100 [it of a 1.0 raM DSNB solution in acetonitrile was 
added to the colloid suspension and the mixture reacted for 8-12 h. Next, excess DSNB was 
removed by centrifuging at 2000g for 10 min and decanting the supernatant. The product was 
again resuspended in 2 mM borate buffer (pH 8.5) containing 0.1% Triton X-100. The 
centrifugation/resuspension process was performed a total of three times for thorough 
removal of excess DSNB. The surfactant aided the dissolution of DSNB and the stability of 
the colloidal suspension without inhibiting the immobilization of the particles to the amine-
modified substrates. The concentration and pH of the buffer used for resuspension reflect 
conditions requisite to avoid particle aggregation and to ensure the presence of deprotonated 
amines on the modified substrate for reaction with the DSNB-labeled nanoparticles. 
The Raman reporter-labeled nanoparticles were passed through a 0.22-p.m syringe 
filter to remove aggregates. The thiolate coated substrates were then fully immersed in the 
labeled nanoparticles and allowed to react for 8-12 h. Finally, the prepared substrates were 
rinsed with deionized water and dried with a stream of high purity nitrogen. 
Instrumentation, (i) SERS Measurements. Raman spectra were collected with a 
NanoRaman I (Concurrent Analytical). This instrument is equipped with a 632.8 nm He-Ne 
laser with an incident power of 30 mW. The spectrograph has a resolution of 6-8 cm"1 and 
consists of an f/2.0 Czerny-Turner imaging spectrometer. The CCD (Kodak 0401E) is 
thermo-electrically cooled to 0°C. SERS spectra of the Raman-reporter labeled nanoparticles, 
after their immobilization on a substrate, were obtained by focusing the laser light on the 
surface at an angle of incidence 58° from the surface normal, using an objective with a 6.1-
mm focal length and a numerical aperture of 0.40. The irradiated area on the surface is ~ 
4000 )_im . The same objective was used to collect the scattered light. The SERS spectra of 
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the nanoparticle suspensions were obtained with the same instrument by focusing the laser 
light into a quartz cuvette. All spectra were integrated for 1 s. 
(ii) UV-VIS Spectroscopy. UV-VIS extinction spectra were collected in an external 
reflection mode with a Hewlett-Packard 8453 spectrophotometer. Spectra were obtained with 
/^-polarized, s-polarized, or unpolarized light incident at ~58° with respect to the surface 
normal, and integrated for 0.5 s at a resolution of 1 nm. The results are presented as -
log(R/Ro), where R is the reflectance of the sample substrate and Ro is the reflectance of an 
uncoated template-stripped gold or template-stripped silver reference substrate. In most 
cases, the experimentally determined extinction spectra are presented after normalization 
with respect to their individual extinction maximum.31 This approach arises from two factors. 
First, the substrates are smaller than the light beam (1.5 cm) and not uniform in size, which 
led to sample-to-sample variability in the amount of reflected light. Second, we did not 
attempt to control the surface concentration of the immobilized nanoparticles. These factors 
resulted in the inability to interpret the magnitude of extinction as due only to differences in 
SPR. There is, however, no effect on the position of the extinction maximum, and the use of 
normalization facilitates comparisons of peak positions. 
(Hi) AFM Imaging. The nanoparticle surface concentration on each substrate was 
measured with a Dimension AFM (Digital Instruments). The AFM was operated in 
TappingMode at a scan rate of 1.5 Hz, maintaining a constant setpoint oscillation amplitude 
at 80% of the free amplitude. The n(+)-silicon TESP probes (Nanosensors) used for imaging 
were 118 \xm long, 27-29 p.m wide, and 3.6-4.5 urn thick, with a spring constant of 32-70 
N/m and a resonant frequency of 327-421 kHz. 
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Images (5x5 [xm) were collected on five different areas of each sample, with the 
number of nanoparticles in each image enumerated manually and then averaged for each 
sample. There was no indication of aggregation of labeled particles dispersed in solution, 
based on the UV-VIS extinction spectra. Moreover, there was no evidence for particle 
aggregation in the AFM images. 
Theory 
Earlier approaches to the calculation of the polarizability of a nanosphere above a flat 
substrate of semi-infinite thickness employed the dipole approximation.47 This calculated 
polarizability was then used to model an extinction spectrum. However, results showed that 
higher-order multipoles must be considered in order for the calculated polarizability of the 
particle to be reliable in predictions of the experimentally observed extinction spectrum.47 
Both Aravind and Wind each developed methods to solve the Laplace equation for this 
system that includes the effects of multipoles.45'46 Both models give identical solutions, but 
utilize different coordinate systems. The key points of Wind's model are briefly described. 
According to Wind's model, the polarizability of the nanoparticle is influenced by the 
dielectric functions of the ambient, underlying substrate, and nanoparticle; the nanoparticle 
radius; the nanoparticle-substrate separation; and the incident angle of the radiating source. 
In addition, the polarizability of a nanoparticle above a substrate is dependent upon the 
polarization of the incident light. That is, an electric field polarized perpendicular to the 
substrate will induce an image charge distribution of the bound particle in the substrate that is 
in phase with that induced in the nanoparticle. The resulting image charge will increase the 
polarization of the particle. When the incident field is polarized parallel to the surface, 
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however, the image charge is opposed to the induced charge distribution of the nanoparticle 
and therefore reduces the polarization of the particle. 
As a starting point, we calculated extinction spectra for gold nanoparticles suspended 
in close proximity to a flat gold substrate using Wind's method to determine polarizability. 
However, those results did not agree well with the experimental observations. Work with 
isolated spherical particles has shown that surface scattering effects,48 radiation damping, and 
dynamic depolarization49 must be considered to account for size effects. In search of better 
agreement between experimental and theoretical results for our system, we have incorporated 
these corrections for size effects into Wind's method. We found that for the size of particles 
used in our studies (30-100 ran), surface scattering effects are small, and the correction factor 
is dominated by consideration of radiation damping and dynamic depolarization. 
Results and Discussion 
1. Measurements of the SPR for Immobilized Gold Nanoparticles. The above 
model predicts that particle size (r), gap distance (d), and dielectric functions of the 
nanoparticle (£3), substrate {ei), and ambient (^i) will all have an effect on the extinction 
spectrum of immobilized nanoparticles. In this section, we explore the role of these factors 
and demonstrate control over SPR by experimentally varying r, d, and £3. The experimental 
results are then compared to predictions by the model. 
1.1 Effect of Nanoparticle Immobilization and Size on SPR. Figures 1-3 present a 
series of experimental spectra that begins to reveal the plasmon interactions between the 
immobilized gold nanoparticles and the underlying gold substrate. Each spectrum in Figures 
1 and 2 is normalized with respect to its maximum extinction to highlight the wavelength 
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shifts. The extinction spectra of the five sizes of DSNB-labeled gold nanoparticles, all 
suspended in borate buffer (pH 8.5), are shown in Figure 1. The extinction maxima undergo a 
red shift from 529 to 565 nm as the nanoparticle diameter increases from 30 to 100 nm. 
These shifts follow expectations of the wavelength dependence of SPR on particle size.50 The 
peak widths are also observed to increase with particle diameter, which in addition to the 
effects of dynamic depolarization and radiation damping, results from a greater absolute size 
distribution for larger particles. 
Figure 2 shows thep-polarized extinction spectra for the same set of DSNB-labeled 
gold nanoparticles after immobilization on gold substrates that were previously modified 
with an AET spacer and then dried under a stream of high purity nitrogen. The observed 
relationship between nanoparticle size and the wavelength of the extinction maximum for the 
immobilized nanoparticles follows the same trend found for the suspended nanoparticles. 
Further comparisons of the two sets of spectra reveal a much larger red shift in the extinction 
maximum for each size of immobilized nanoparticles. As a consequence of immobilization, 
the extinction maxima move from 596 to 755 nm as the particle diameter increases from 30 
to 100 nm. Immobilization therefore shifts the extinction maximum of the 30-nm particles by 
almost 70 nm. The change is even more dramatic upon immobilization of the 100-nm 
particle, ~190nm. 
These shifts are only observed when the incident light is/?-polarized. As shown in 
Figure 3, there is no detectable shift in the extinction spectra collected for the same samples 
with 5-polarized light. The feature at -530 nm in Figure 3 is also observed in Figure 2, where 
it results from the component of the jp-polarized light that is parallel to the surface. We 
further note that this band arising from the parallel component of the electric field is blue 
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shifted for the immobilized particles compared to that of the suspended particles because of 
differences in the dielectric constant of the surrounding media (air vs. water). 
The above findings support the existence of a strong coupling interaction between the 
polarized nanoparticle irradiated withp-polarized light and the image charge formed in the 
underlying gold substrate. This interaction results in a large shift in the plasmon resonance of 
the system. Since the electric field for s-polarized light is in the plane of the substrate, the 
induced image charge opposes that of the particle and markedly dampens polarization. 
1.2 Effect of Gap Distance on SPR. The above results show that coupling between a 
nanoparticle and a smooth gold surface in close proximity can have a dramatic effect on the 
SPR of the gold nanoparticles and that particle size can serve as a potential control parameter 
to vary SPR. Moreover, theory predicts that the location of the SPR maximum is extremely 
sensitive to nanometric differences in the separation between the substrate and nanoparticle. 
To test this prediction, the particle-substrate separation, d, was varied by using AET and 
AUT, which form gold-bound thiolates with different chain lengths. As such, a DSNB-
labeled nanoparticle bound to the substrate via AET yielded a gap of ~1.2 nm, while that 
bound to the substrate via AUT gave a gap of -2.3 nm; both values are based simply on CPK 
modeling (Harvard Apparatus) and include both the thickness of the spacer and DSNB. 
Unpolarized UV-VIS spectra comparing 60-nm DSNB-labeled nanoparticles 
immobilized on a gold substrate with AET and AUT are shown in Figure 4. The spectrum for 
the particle suspension is included, a situation analogous to an infinite gap.51 The 60-nm 
nanoparticle has an extinction maximum at 539 nm in solution, 611 nm when bound to AUT, 
and 657 nm when linked to AET. The red shift is therefore 71 nm when the nanoparticles are 
brought to within 2.3 nm of the surface and increases an additional 46 nm when the gap is 
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reduced by 1.1 nm. Red shifts were also observed for the same reduction in gap distance with 
each of the different sizes of nanoparticles. These results are summarized as part of Table 1. 
We therefore find that the SPR for this system is very sensitive to the gap distance, which 
further supports the existence of nanoparticle-substrate coupling given that greater changes in 
SPR are detected as the separation decreases. Thus, gap distance, like nanoparticles size, can 
serve as another parameter for manipulation of SPR. 
1.3 Effect of Substrate Material on SPR. Theoretical models also indicate that SPR 
of a nanoparticle suspended over a flat substrate is dependent upon the dielectric function of 
the substrate. To experimentally probe this prediction, the gap between the particle and 
substrate was held effectively constant by using an AET monolayer for particle 
immobilization, but the underlying substrate is switched from gold to silver. It is known, 
however, that the thiolate chain tilt is ~30° on gold and -10° on silver,52 which would 
translate to gaps of 1.2 nm and 1.3 nm, respectively. Figure 5 shows the resulting UV-VIS 
spectra, collected using unpolarized incident light and normalized with respect to their 
extinction maximum, for 60-nm DSNB-labeled gold nanoparticles. In both cases, there is a 
strong shift in the extinction maximum to longer wavelengths with respect to that at 539 nm 
for the nanoparticle suspension. The extinction maximum for a 60-nm nanoparticle on silver 
appears at 617 nm, whereas that on gold is at 657 nm. The shift at gold is therefore -40 nm 
larger than at silver. The same types of dependencies were found for each size of tested 
nanoparticles (Table 1); the extinction peak for a given nanoparticle size and gap distance is 
located at longer wavelengths when bound to a gold substrate compared to a silver substrate. 
Thus, the choice of substrate is a third method of controllably tuning SPR. 
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2. Calculation of the Extinction Spectra of Immobilized Gold Nanoparticles. 
Extinction spectra were calculated, as discussed above, to investigate the expected influences 
of nanoparticle size, nanoparticle-substrate separation, and substrate material and for 
comparison to our experimental findings. The polarizability was calculated using the first 40 
terms in the infinite series solution to Wind's model53 and corrected for radiation damping 
and dynamic depolarization.49 The values for the wavelength dependent dielectric function of 
the nanoparticles were taken from literature,54 interpolated to 1-nm increments, and corrected 
for surface scattering effects.55 However, a determination of a value for the dielectric 
constant of the ambient (^i) proved difficult because the particles were coated with a thiolate 
monolayer and separated from the substrate by another thiolate monolayer. Our approach 
was to test various values for e\, which would then represent a single effective dielectric 
constant incorporating the contribution of the thiolate layers for the system in which 30-nm 
particles are immobilized on a gold substrate via AET, and surrounded by air. This empirical 
approach established that an S\ of 1.21, a value that reasonably lies between those of air and 
condensed hydrocarbon phase, produced similar predicted and measured locations of the 
plasmon resonance peak. This value of S\ was then employed in the calculations for all our 
systems, using the vendor-specified sizes for the nanoparticles, the CPK modeled gap 
distance, and an incident angle of 58°. 
First, the influence of immobilizing gold nanoparticles on a gold substrate was 
studied for particle diameters ranging from 30 to 100 nm, by calculating the extinction 
spectra shown in Figure 6. This set of calculations was performed for only the/?-polarized 
contribution of the incident electric field to the extinction efficiency, a gap distance of 1.2 nm 
to mimic the effect of the AET spacer, and the dielectric function of gold for the underlying 
91 
substrate and immobilized nanoparticles. The calculated spectra reveal that the SPR peak 
shifts to longer wavelengths as the particle diameter increases, which tracks with the 
experimental findings. Moreover, as summarized by the inset in Figure 6, the calculated 
extinction maxima closely match those that were experimentally measured. The calculated 
magnitude of extinction also undergoes a strong size dependence by increasing with particle 
size. However, a comparison of these results with measured values cannot be made due to 
experimental limitations already discussed. We add that the experimentally measured 
extinction peaks are broader than predicted with this model; this is likely due to a distribution 
of nanoparticle sizes and shapes. 
We next investigated the theoretical prediction of the influence of the gap distance on 
the extinction spectra. An example set of calculated extinction spectra is shown in Figure 7. 
These calculations were performed using both the/?-polarized and ^-polarized contributions 
to the extinction efficiency to facilitate comparisons to the experimental data obtained using 
an unpolarized light beam. The spectra computations paralleled those used to construct the 
plots in Figure 6, except that values of 1.2 and 2.3 nra for the nanoparticle-substrate 
separation were used to account for and compare the contributions of the AET and AUT 
linkages. The calculated extinction band is red shifted for the 1.2-nm gap compared to the 
2.3-nm gap by 48 nm. This difference agrees well with the 46-nm shift observed 
experimentally. Agreements within ~10 nm were also found for the other sizes of 
nanoparticles (Table 1). 
The last set of calculations probed the difference in the SPR for nanoparticles 
immobilized on a gold versus a silver substrate and the resulting spectra are given in Figure 
8. The calculations were again performed using both the/?-polarized and s-polarized 
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contributions to the extinction efficiency, a nanoparticle diameter of 60 nm, a nanoparticle-
substrate gap of 1.2 nm or 1.3 nm to reflect differences in alkane chain tilt angles,52 and the 
dielectric function of a gold or silver substrate. Based on differences in the dielectric 
functions of the substrate, the results predict a red shift for nanoparticle immobilization on a 
gold substrate compared to that on a silver substrate, which agrees with the experimental data 
(Table l).56 
3. Optimizing SERS Enhancement Factors of Immobilized Gold Nanoparticles. 
One of the critical mechanistic underpinnings for SERS is the enhancement of the electric 
field at the surface of the nanoparticle. The SERS gain is maximized when the surface 
plasmon resonance couples to the electric fields generated at both the wavelength of the 
excitation source (/{,«) and that of the scattered radiation (/lsc). This coupling is optimized 
when the surface plasmon resonance wavelength is centered between ^ and Asc.i6'19'26'57 
DSNB, which is used to coat the gold nanoparticles, has the following Raman-active bands: a 
symmetric nitro stretch at 1336 cm"1, a nitro scissoring vibration at 851 cm"1, an aromatic 
ring mode at 1566 cm"1, and an overlap of the N-C-0 succinimidyl stretch with an aromatic 
ring mode at 1079 cm"1.7 Of these modes, the nitro stretch at 1336 cm"1 is the most 
intrinsically intense feature and is used for comparisons of SERS enhancement factors. The 
laser source excites the samples at 632.8 nm (A^); thus, the position for the Stokes shifted 
nitro stretch is 690 nm (Asc). We therefore hypothesized that a surface plasmon resonance 
located at ~660 nm will maximize the enhancement factor. To test this theory, the following 
sections vary the parameters found to influence SPR in Section 2 and measure the SERS 
signal in an effort to make connections between SPR and SERS enhancement. 
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3.1 Effect of Nanoparticle Immobilization and Nanoparticle Size on the SERS 
Enhancement Factor. No observable Raman signal is obtained from DSNB-labeled 
nanoparticles with diameters of 30 to 100 ran for suspensions at the as-prepared 
concentrations (2.0 x 1011 to 5.6 x 109 particles/mL). These concentrations correspond to the 
C O 
presence of an estimated 2500 to 84000 particles in the laser focal volume. As shown 
below, this number of particles is similar to the number of immobilized particles irradiated in 
the ~4000 (am focused laser beam, however, the immobilized particles give rise to a strong 
SERS signal. This result is consistent with expectations since the X.max for the SPR of the 
suspended nanoparticles ranges from 529 to 565 nm, and very little coupling to Agx (633 ran) 
and Asc (690 nm) occurs. 
Binding the nanoparticles to gold substrates greatly affects the SERS signal. Figure 9 
shows the raw SERS spectra for DSNB-labeled nanoparticles, 30 to 100 nm in diameter, that 
are immobilized on an AET-coated gold substrate. Strong SERS responses that are consistent 
with the various vibrational modes of DSNB are observed in each instance. While it at first 
appears that the 80-nm nanoparticles give the largest enhancement, the surface 
concentrations of each of the substrates differ. To account for this variation, AFM images 
were collected for each sample and the nanoparticle surface concentrations (particles/fim2) 
were measured. 
Representative AFM images for samples prepared with 60- and 80-nm particles are 
shown in Figure 10. The images confirm that particles are present and randomly distributed 
on the surface, and that the sizes fall within the specified ±8% size range. While the particles 
appear larger than the vendor-specified sizes in the x-y plane, this is a manifestation of tip 
convolution effects,59 and a detailed examination of the measured nanoparticle heights (data 
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not shown) confirms the expected sizes. The SERS peak intensity for each of the prepared 
substrates was then divided by the nanoparticle coverage to determine a relative SERS signal 
per nanoparticle. These results are also reported in Table 1. As is evident, both 80- and 100-
nm nanoparticles give the largest relative signal per particle. 
The signal per nanoparticle, for each nanoparticle size, can clearly be affected by a 
difference in the number of scattering molecules due to the dependence of particle surface 
area on particle diameter. This difference must be factored out in order to more effectively 
compare the SERS enhancement as a function of each of the experimentally manipulated 
variables. Assuming the number of DSNB molecules per nanoparticle is proportional to 
nanoparticle surface area, the relative signal per particle can be divided by the nanoparticle 
surface area (nm2/particle) to calculate the relative SERS enhancement factor (EF). This 
calculation gives the relative SERS EF per DSNB adsorbate. 
The relative EFs calculated in this manner are reported in Table 1 for each set of 
nanoparticles. The EF reaches a maximum as the maximum of the SPR approaches the 
midpoint between the excitation source (633 nm) and the scattered band (690 nm). For the 
case of particles immobilized on a gold substrate via AET, as shown in Table 1, 60-nm 
nanoparticles result in the greatest EF. The UV-VIS absorption peak for this sample is 
located at 657 nm, close to the A.max of the SPR value predicted to yield the greatest EF (i.e., 
660 nm). 
3.2 Effect of Gap Distance on SERS Enhancement Factor. To determine the 
influence of the gap distance on the EF, nanoparticles immobilized with AET and AUT on a 
gold substrate that have the same SPR A.maX must be compared. It follows, from Section 1.2, 
that 60-nm particles immobilized with AET and 80-nm particles immobilized with AUT, 
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both on gold substrates, have similar values of X,maX, 657 nm and 652 ran, respectively. The 
relative signal per nanoparticle and the relative EF per DSNB molecule are given in Table 1 
for each of these systems. The EF is much greater for the 60-nm nanoparticles bound with 
AET than for the 80-nm particles bound with AUT. The EFs are greater for every substrate 
tested that had similar extinction peaks but a smaller gap distance. This trend is easily 
visualized in Figure 11; at a given SPR, the EF is ~5 times greater for the 1.2-nm gap 
compared to the 2.3-nm gap. Thus, EFs are dependent upon the gap distance in addition to 
the SPR A-max- We believe that this observation highlights the importance of the local field 
magnitude on surface enhancement. Earlier reports have found larger electric field 
magnitudes (i.e., "hot spots") between coupling bodies (i.e., particle-particle and particle-
substrate), and that the magnitude of the field increases as the separation decreases.60"62 
3.3 Effect of Substrate Material on SERS Enhancement Factor. Sections 3.1 and 
3.2 show that the maximum EF is obtained for a sample with an SPR Xmax close to 660 nm 
when the substrate material and gap distance are held constant. Therefore, to determine the 
influence of the underlying substrate on EF, nanoparticles immobilized with an effectively 
constant gap distance and the same SPR A,max must be contrasted. As shown in Section 1.3, 
60-nm particles immobilized on gold and 80-nm particles immobilized on silver, both with 
AET, have similar values of X.max, 657 nm and 663 nm, respectively. The relative signal per 
nanoparticle and the relative EF per DSNB molecule are given in Table 1 for each of these 
systems. The EFs are comparable for both substrates. Moreover, the EFs are found to be 
similar for every gold and silver substrate tested that had similar extinction peaks for a given 
gap distance. Thus, while the substrate material affects the surface plasmon, similar upper 
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limits in EF can be attained as long as the nanoparticle sizes are selected to yield matching 
SPRs. 
Conclusions 
This paper demonstrates control over the SPR ^max, and therefore, the SERS 
enhancement factor, for nanoparticles immobilized on a metal substrate. The absorption peak 
undergoes a red shift as the nanoparticle size increases and the gap distance decreases. 
Furthermore, a red shift was discovered for nanoparticles of the same size immobilized on a 
gold substrate compared to a silver substrate. This study also found that the SERS EF 
maximizes with the simultaneous minimization of gap distance and approach of the SPR Km* 
to the midpoint between Xex and Xsc. Thus, the SERS intensity can be optimized by varying 
the nanoparticle size, particle-substrate separation, and substrate material. These results lay 
the foundation necessary to design an optimized assay with the potential to measure SERS 
from a single nanoparticle in our SERS-based immunoassay without the need of a resonance 
Raman reporter molecule. 
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Figure Captions 
Figure 1. The experimentally measured UV-VIS extinction spectra for different sizes of 
DSNB labeled gold nanoparticles suspended in 2 mM borate buffer (pH 8.5) containing 0.1% 
Triton X-100. Each spectrum is normalized with respect to its maximum extinction to 
account for differences in particle concentrations. The inset is a plot of the peak position as a 
function of particle diameter. 
Figure 2. The experimentally measured/^-polarized UV-VIS extinction spectra for different 
sizes of DSNB-labeled gold nanoparticles immobilized on an AET-modified gold substrate. 
Each spectrum is normalized with respect to its maximum extinction to account for substrate 
size and nanoparticle coverage variations. The inset is a plot of the peak position as a 
function of particle diameter. 
Figure 3. The experimentally measured s-polarized UV-VIS extinction spectra for different 
sizes of DSNB-labeled gold nanoparticles immobilized on an AET-modified gold substrate. 
Figure 4. The measured UV-VIS extinction spectra for 60-nm DSNB-labeled gold 
nanoparticles as a suspension and immobilized with AET and AUT on a gold substrate using 
unpolarized light. The dielectric function of the surrounding environment is that of water for 
the suspended particles and a mixture of an organic phase and air for the immobilized 
particles. Each spectrum is normalized with respect to its maximum extinction to account for 
substrate size and nanoparticle coverage variations. 
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Figure 5. The experimentally measured UV-VIS extinction spectra for 60-nm DSNB-labeled 
gold nanoparticles immobilized with AET on gold and silver substrates using unpolarized 
light. Each spectrum is normalized with respect to its maximum extinction to account for 
substrate size and nanoparticle coverage variations. 
Figure 6. The calculated/^-polarized UV-VIS extinction spectra for different sizes of DSNB-
labeled gold nanoparticles, solved with a 1.2 nm gap distance between the nanoparticle and 
an underlying gold substrate. The inset compares the calculated to the experimental peak 
locations. 
Figure 7. The calculated UV-VIS extinction spectra using unpolarized light for 60-nm 
DSNB-labeled gold nanoparticles immobilized with AET and AUT on a gold substrate. 
Figure 8. The calculated UV-VIS extinction spectra using unpolarized light for 60-nm 
DSNB-labeled gold nanoparticles immobilized with AET on gold and silver substrates. 
Figure 9. The SERS spectra for different sizes of DSNB-labeled gold nanoparticles 
immobilized on a gold substrate with AET. The spectra are offset for visualization. 
Figure 10. AFM images (5x5 urn) of 60 nm (left) and 80 nm (right) gold nanoparticles 
immobilized on a gold substrate with AUT. 
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Figure 11. Plot of relative SERS enhancement factor as a function of surface plasmon 
resonance wavelength. The two sets of data (circles and squares) are for substrates created at 
two different gap distances. The vertical dashed lines represent X.ex (left) and A.sc (right). 
Table 1. Comparisons of SPR T^nax and SERS EF for nanoparticles in close proximity to a 
metallic substrate, and the impact of changes in particle size, particle-substrate separation, 
and dielectric function of the substrate. 
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Table 1 
Substrate 
Gold 
Gold 
Gold 
Gold 
Gold 
Gold 
Gold 
Gold 
Gold 
Gold 
Silver 
Silver 
Gap 
(nm) 
1.2 
1.2 
1.2 
1.2 
1.2 
2.3 
2.3 
2.3 
2.3 
2.3 
1.3 
1.3 
Particle 
Size (nm) 
30 
50 
60 
80 
100 
30 
50 
60 
80 
100 
60 
80 
SPRXmaxfnm) 
Measured 
596 
625 
657 
712 
755 
566 
596 
611 
652 
679 
617 
663 
Calculated 
594 
636 
658 
703 
754 
561 
594 
610 
650 
698 
623 
668 
Normalized SERS Signal 
Particle Density 
(cts*|im2)/(s*particle) 
121 
759 
4572 
5904 
5939 
10.5 
79 
294 
2116 
2415 
1436 
9135 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
4 
46 
77 
354 
297 
1.1 
4 
15 
254 
121 
59 
457 
OSNB Surface 
Concentration 
(cts*nm2)/(s*nm2) 
0.043 ± 0.001 
0.10 ± 0.01 
0.41 ± 0.07 
0.29 ± 0.02 
0.19 ± 0.01 
0.0037 ±0.0004 
0.010 ± 0.001 
0.026 ± 0.001 
0.11 ± 0.01 
0.077 ± 0.004 
0.13 ± 0.01 
0.45 ± 0.02 
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VIA CAPTURE SUBSTRATE ROTATION: AN ABSOLUTE 
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Abstract 
Immunosorbent assays are commonly employed as diagnostic tests in human 
healthcare and veterinary medicine and are strongly relevant to the methodologies for 
bioterrorism detection. However, immunoassays often require long incubation times, limiting 
sample throughput. As an approach to overcome this weakness, this paper examines the use 
of rotating capture substrates to increase the flux of antigen to the surface, thereby reducing 
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the incubation time. To assess the capability of this approach, porcine parvovirus (PPV) was 
selectively extracted from a sample solution exposed to a gold substrate modified with a 
covalently immobilized layer of anti-PPV monoclonal antibodies. The captured PPV were 
then directly imaged and quantified by atomic force microscopy. Substrate rotation rates 
were systematically varied to control the flux of PPV to the capture surface. Analysis of the 
experimental results, in combination with established theory for rotation-induced flux, allows 
an accurate determination of PPV concentration. Furthermore, the relationship between the 
quantal concentration units of 50% tissue culture infective dose (TCTD50) and quantitative 
concentration units of viruses/mL can be calculated. The benefits of substrate rotation are 
demonstrated by comparing dose-response curves, established by exposing the capture 
platform to the sample solutions for 10 min at 25°C, for an immunoassay performed under 
stagnant conditions to one performed with substrate rotation at 800 rpm. The limit of 
detection (LOD) improved to 3.4 x 104 TdD50/mL (-80 fM) by rotating the capture 
substrate at 800 rpm from an LOD of 3.2 x 105 TdD50/mL (-800 fM) under stagnant 
conditions. The potential to broadly apply this technique to heterogeneous immunoassays is 
also briefly discussed. 
Introduction 
Immunoassay development continues to be one of the most active areas at the 
interface between the analytical and biological sciences.1'2 This situation results in large part 
from the ever-increasing demand for diagnostic tests in human healthcare and veterinary 
medicine that enhance throughput, simplify sample workup, reduce analysis time, and lower 
the level of detection. Advances to these ends will not only improve chances for early 
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diagnosis and thereby increase the likelihood of successful treatment and recovery, but also 
reduce the potential spread of disease and decrease the length of possible hospitalization.3 
This same set of advances is central to addressing challenges in bioterrorism prevention.4 
Recent breakthroughs in electrochemical, optical, magnetic, scanning probe 
microscopic, and several other detection modalities are poised to meet these needs.5"16 These 
developments have pushed the limit of detection to femtomolar levels and lower, 
performances that translate to a response of only hundreds to thousands of analytes when 
dealing with the microliter sample volumes accessible with emerging microfluidic constructs. 
The challenge with such systems, however, is that when the mass transfer of analyte is 
governed solely by diffusion, incubation times of several hours may be required when 
analyzing biological samples. This situation arises because diffusion coefficients for proteins 
and other large biolytes can be a few orders of magnitude lower than those for small 
molecules. In fact, recent theoretical treatments argue that the time required for low-level 
(i.e., picomolar or less) detection is unacceptably long for assays which rely only on the 
diffusional transport of large biolytes to recognition elements immobilized on surfaces in a 
biochip format. This treatment suggests that the detection levels reported for some assays 
may reflect a limitation in mass transfer and not necessarily signal transduction. The 
challenge then is to develop strategies that rapidly transport the antigen to the capture 
substrate in order to take advantage of the emerging breakthroughs which enable 
quantification of exceedingly low amounts of material. Moreover, the potential to capitalize 
on enhancements in the flux of antigen is supported by research that has repeatedly shown 
that the rate of heterogeneous antibody-antigen binding is limited by antigen mass transport 
rather than by binding kinetics (i.e., recognition rate).18"22 
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Several laboratories have examined methods aimed at decreasing incubation times by 
increasing the flux of analyte to the capture substrate. For example, electric fields have been 
shown to drive the rapid transport of single-stranded DNA across a 200-um solution layer, 
completing a hybridization-based assay in less than 7 s. The same general concept has been 
used to direct the transport of antigens in completing a heterogeneous immunoassay in ~1 
min.24 Another example employed fluid confinement concepts to limit the flow profile of the 
antigen to a thin layer above a capture antibody substrate; this strategy, consistent with 
earlier predictions by computational models, reduced the incubation time fourfold over 
static conditions.26 Elevations in temperature,27 which result in a decrease in solution 
viscosity, have also been found to reduce incubation times. 
The work presented in this paper utilizes the rotation of capture antibody substrates as 
a means to increase the flux of antigen to the surface. Rotation is a well characterized method 
of controlling flux to a surface, and has historical precedence in electrochemistry where 
rotating disk electrodes (RDE) are used to manipulate mass transport in studies of electrode 
reaction mechanisms. RDEs have also been employed in immunoassays during the 
amperometric detection step of redox probes that were generated by an enzymatic label in a 
sandwich-type assay.28"30 To our knowledge, only one example has taken advantage of 
rotation as a means to increase the flux of antigen to the capture substrate, and thereby 
decrease incubation times.31 However, the goal of that study was solely to control mass 
transport in order to develop an assay in which the quantitative detection of antigen binding 
was independent of sample volume. The initial aim of the work herein was to reduce 
incubation times for the ultra-low level detection of viruses; a goal that, as we will show, was 
achieved. 
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This paper also reports on another interesting finding that developed over the course 
of this work—rotation-induced flow facilitates the accurate determination of virus 
concentration without the use of standards. Typically, virus concentrations are estimated with 
quantal rather than quantitative techniques.32 These techniques, which include infectious and 
hemagglutination titrations and plaque assays, approximate virus concentrations in units of 
50% tissue culture infective dosage (TCID50), hemagglutination units (HA), or plaque-
forming units (PFU), respectively. While quantal techniques have proven highly effective, 
concentrations given as the number of virus particles per unit volume represent a more 
effective means for assessment of assay performance and, ultimately, diagnostic utility. The 
ability to quantitate the number of viruses per unit volume is also necessary in order to 
accurately determine the total nucleic acid or capsid protein content in a particle for 
determinations of virus structure.33 
At present, transmission electron microscopy (TEM) is the standard for the 
measurement of virus concentration in terms of virus particles per unit volume.33 This 
method requires drying a known volume of virus on a TEM grid, enumerating the viruses in 
a well defined area on the grid, and extrapolating this value to represent the number of 
viruses on the droplet-coated surface. However, the reliable implementation of this approach 
requires highly purified virus solutions, the accurate transfer of small sample volumes to the 
TEM grid, and may be affected by clumping and other artifacts induced by drying. The 
analysis of the images also assumes that the observed coverage of the virus is uniform across 
the dried sample which is difficult to assess and control. The combined weight of these 
factors severely limits the reliability of this method.33 
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We show that rotating capture antibody substrates markedly lower the time required 
for sample incubation, result in a uniform antigen distribution on the surface, eliminate the 
need for virus purification, and can be used to determine virus concentration as viruses per 
unit volume. This quantitative technique can then be used to determine the relationship 
between the quantal units per unit volume (i.e., TCID50, HA, and PFU) and viruses per unit 
volume. 
Evaluation of our approach was performed with the capture of porcine parvovirus 
(PPV) (~25-nm diameter) on a rotating capture substrate. The capture substrate, which has 
been previously constructed in our laboratory,9'34 has an anti-PPV monoclonal antibody 
(mAb) covalently coupled to a gold surface through a gold-bound thiolate formed from 
dithiobis(succinimidyl propionate). The capture substrate is then inverted, attached to a 
rotating rod, and submerged in sample solution. After extraction of the PPV from sample 
solution, the viruses are enumerated utilizing an atomic force microscope (AFM). The 
capability of AFM as an analytical tool for imaging nanometer-sized objects, such as viruses, 
has recently been demonstrated.12'34'35 Direct readout of antigen binding (i.e., label-free 
detection) eliminates any potential complications of modeling antigen binding that may occur 
due to labeling; however, many other readout methods (e.g., electrochemical, optical, 
magnetic, etc.) could be used. The experiments described herein were designed to examine 
the effect of substrate rotation rate and sample incubation time on the amount of virus bound 
to the capture platform as well as to quantitatively compare immunoassay performance with 
rotation to immunoassay performance under stagnant conditions. The findings of these 
experiments are discussed in light of theoretical expectations derived from established RDE 
theory. 
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Theory 
The flux of material delivered to a rotating, planar substrate is well understood and 
can be quantitatively formulated for systems which meet the following criteria: 1) the bulk 
concentration of analyte in the sample solution is constant over the course of the experiment; 
and 2) the rate of the reaction at the substrate surface is mass transport limited (rather than 
kinetically limited). With these boundary conditions, theoretical treatments have been 
developed to quantitatively describe the mass transfer of analyte to an electrode surface for a 
wide range of electrochemical processes.36 The same theory can be applied to a 
heterogeneous immunoassay provided that: 1) binding sites on the capture substrate are not 
saturated with antigen; 2) bulk antigen concentration in the sample solution does not vary 
during the time of incubation; and 3) antibody-antigen binding step is much faster than the 
delivery of antigen to the substrate. As we will show, the resulting theory allows the quantity 
of extracted antigen to be predicted, highlighting not only the importance of the antigen 
diffusion coefficient but also accentuating the need for increased mass transport for large 
molecules. 
Using these boundary conditions, the diffusional-flux of antigen to the sensing 
surface {Jdifj) and the accumulated surface concentration (r„) over time can both be 
calculated by modified forms of the Cottrell equation,37'38 and are given by Equations 1 and 
2, respectively 
2 V -V JDiff=-D/lCbt^ (1) 
n 
2 V V Ta=-DAC/* (2) 
7t 
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where D is the diffusion coefficient of the antigen, Q,is the bulk antigen concentration, and t 
is time. 
Equations 1 and 2 detail the temporal evolution of the antigen delivery rate and 
accumulation on a capture antibody substrate. Both Equations 1 and 2 also indicate that the 
delivery and accumulation of antigen at the surface of a capture substrate are directly 
proportional to D . This dependence indicates that a 100-fold difference in the diffusion 
coefficient of the antigen translates to a 10-fold difference in antigen accumulation. 
Moreover, Equation 2 shows that accumulation increases with t . 
Q 
Figure 1 plots the accumulation of antigen (Cb= 1.00 x 10 antigen/mL) at a surface 
as a function of time for two different diffusion coefficients, one typical of small molecules 
(D = 1.00 x 10"5 cm2/s) and the other serving as an example of a large analyte (D = 1.75 x 10' 
cm /s). It is evident that r„ increases much faster for the small molecule compared to the 
large molecule. This plot illustrates the significance of incubation time prior to readout and 
emphasizes the need for increased mass transport in the case of a large analyte. 
As noted earlier, a rotating disk configuration is an effective means in which to 
manipulate the rate of antigen binding because the hydrodynamic conditions that control the 
flux of material to a planar substrate are well understood and can be quantitatively 
formulated. Figure 2 depicts the key concepts of the system hydrodynamics, which involve 
convective mass transfer to establish steady-state conditions. As such, a rotating rod stirs the 
bulk solution at a carefully controlled and constant rate while delivering it to the surface of 
the disk at a quantifiable rate. Rotation also sets up a stagnant layer of solution at the disk 
surface, commonly referred to as the diffusion layer, in which an analyte must diffusively 
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pass through to reach the disk. The convective-flux induced by rotation can be formulated by 
starting with Equation 337 '38 
D 
J =—Ch (3) 
where £is the diffusion layer thickness at the surface created by rotation. Importantly, the 
diffusion layer thickness is controlled by rotation rate; larger rotation rates decrease the 
thickness, increasing the flux of the analyte. The thickness of the diffusion layer at the 
surface of a disk as a function of rotation velocity, as developed in a model by Levich,39 is 
given by 
S = l.6lV^6 D^ci^2 (4) 
where Sis in units of cm, D is in units of cm2/s, V represents the kinematic viscosity of the 
sample solution (cm /s), and &>is the angular rotation rate of the substrate (radians/s). 
Equations 3 and 4 can be combined to provide an expanded description of antigen flux to the 
substrate for the steady-state case imposed by substrate rotation. This step yields 
j = ^ % w x (5) 
com 1/ \ / 
\.6\V/6 
Ultimately, the surface concentration of antigen on the capture substrate can be 
formulated by multiplying the total flux by the incubation time to give 
r . = l ^ c / + ^ % ^ (6) 
n
 l.6W/6 
The first term in Equation 6 accounts for the antigen accumulation in the absence of a steady-
state delivery of solution (i.e., no rotation), but is quickly dominated by the second term once 
steady-state is obtained (i.e., rotation). 
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Equation 6 shows that for a given sample, the number of antigens bound to the 
capture substrate is dependent only upon incubation time and rotation rate. It is important to 
note that because of the boundary conditions imposed earlier, T0 in this expression is 
independent of sample volume. Additionally, Figure 1 demonstrates that the acquisition of 
both large and small antigens at the surface is markedly enhanced by substrate rotation (500 
rpm) compared to antigen accumulation relying completely on diffusion. In both cases, the 
improvements are directly proportional to a/ 2. 
For the purposes of our heterogeneous immunoassay, mass transport of the viral 
antigen to the capture surface is enhanced as the rotation rate increases and the diffusion 
layer decreases in thickness. Thus, it is theoretically possible to maintain or even increase r a , 
while reducing the incubation time by increasing the rotation rate. This relationship suggests 
that the time required to carry out immunoassays previously performed under stagnant 
conditions, can be immensely reduced without sacrificing, and possibly lowering, the limit of 
detection. Furthermore, if D is known and the incubation time and rotation rate are 
controlled, it is possible to quantitate the antigen concentration, Cb, without the use of 
standards by measuring r a , for systems described by Equation 6. 
Experimental 
Reagents. Octadecanethiol (ODT), dithiobis(succinimidyl propionate) (DSP), and 
phosphate buffered saline (PBS) packs (10 mM) were purchased from Sigma. Borate buffer 
packs (50 mM) were acquired from Pierce. Contrad 70 (Micro, Cole-Parmer) was used for 
cleaning glass substrates and two-part epoxy (Epoxy Technology) was employed to construct 
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template stripped gold. All buffers were passed through a 0.22-^im syringe filter (Costar) 
before use. Poly(dimethyl siloxane) (PDMS) was obtained from Dow Corning. 
Anti-PPV monoclonal antibodies (1 mg/mL), supplied by National Animal Disease 
Center (NADC; Ames, IA), were purified with a protein G column (Pro-Chem) and stored in 
10 mM PBS. Aliquots of purified PPV, suspended in 10 mM PBS, were also provided by 
NADC. Detailed procedures for the generation of both the antibodies and the virus have been 
previously reported.40 The PPV concentration of the stock solution was determined from 
titrations to be 3.2 x 109TCID5o/mL using the Reed-Muench method.41 All dilutions of the 
PPV stock solution were made with 10 mM PBS. 
Capture Substrate Preparation/Immunoassay Protocol. Template stripped gold 
(TSG)42 served as the base for fabrication of the capture substrate, noting that its low 
roughness factor (0.6 nm) facilitated the enumeration of PPV (hydrated diameter of-25 nm) 
by AFM.9'12'34 To prepare TSG, 250 nm of gold (99.9% purity) were resistively evaporated 
onto a 4-in p-type silicon [111] wafer (University Wafer) at a rate of 0.1 nm/s by using an 
Edwards 306A resistive evaporator. Next, 1 x 1 cm glass squares, cut from microscope slides 
(Fisher Scientific), were ultrasonically bathed in diluted Contrad 70, deionized water, and 
ethanol, each for 30 min. Epoxy cement was applied to one side of the clean glass chips, 
which were then affixed to the gold-coated silicon wafer and cured at 150° C for -100 min. 
After curing, the glass chips were carefully detached from the wafer, a process that exposes a 
smooth gold surface. 
TSG was exposed to an ODT-saturated PDMS stamp with a 4-mm hole cut in its 
center for -30 s. The TSG was then rinsed with ethanol and dried under a stream of high 
purity nitrogen.43"45 This procedure forms an ODT-derived monolayer on the outer portion of 
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the TSG, which provides a circular hydrophobic barrier to localize reagents on the center of 
the substrate in subsequent steps and minimize both reagent and sample consumption. Next, 
the ODT-inked substrate was submerged in a 0.1 mM ethanolic DSP solution for -12 h, 
rinsed with ethanol, and dried under a stream of high purity nitrogen. This process forms a 
DSP-based adlayer in the center of the substrate, which was not exposed to ODT in the 
stamping process. 
Anti-PPV mAbs (20 uL), diluted tolOO ug/mL in 50 mM borate buffer (pH 8.5), were 
pipetted onto the center of the substrate and allowed to react for 8 h in a humidity chamber at 
room temperature. During this step, a capture antibody layer is formed due to the amide 
linkage that arises from the covalent coupling of the primary amines on the mAbs to the 
terminal succinimidyl ester of the DSP-derived monolayer.46"48 The substrate was immersed 
in 10 mM PBS (2.5 mL) three times to remove unreacted mAbs. After rinsing, the back of 
the capture substrate was quickly dried and attached to an RDE with double-sided tape while 
maintaining a thin layer of buffer on the topside of the substrate in order to ensure continual 
hydration of the mAbs. The RDE-mounted substrate was then loaded into a Pine analytical 
rotator (AFMSRX) and lowered to immerse the capture substrate in a 1.0-mL sample 
containing PPV. The rotation rate of the capture substrate and the incubation time with the 
PPV samples were varied. All sample volumes were held constant at 1.0 mL and all 
incubations were performed at room temperature. After incubation, the substrate was rinsed 
three times with 2.5 mL of PBS, exposed to a gentle flow of deionized water to remove 
residual salts (in order to facilitate AFM imaging), dried with a stream of high purity 
nitrogen, and imaged with AFM. 
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Instrumentation, (i) Rotator and Rotating Rod. The capture substrates were 
rotated with an AFMSRX analytical rotator from Pine Instrument Company. The rotator has 
an accuracy of 1% between 0 and 10,000 rpm. The slew rate of the motor is -300,000 rpm/s; 
therefore, the desired rotation rate is effectively attained instantaneously for the rotation rates 
(50-1200 rpm) and incubation times (10-30 min) used in these experiments. 
The capture substrate, as prepared above, is attached to an E2M single-piece RDE 
(Pine Instrument Company) by double sided tape (3M). This electrode readily mates with the 
AFMSRX rotator, having one end of the rod with a diameter of 6 mm that is clamped into the 
rotator and the other end of the rod (12-mm diameter) that not only fits into a sample well 
(17-mm diameter), but also closely matches the 1 x 1 cm capture substrate. 
(ii) Atomic Force Microscopy (AFM). A MultiMode NanoScope Ilia SFM (Digital 
Instruments), equipped with a 150-^m scanner, was used to image viruses bound to the 
capture substrates. The AFM was operated in TappingMode under ambient conditions. An 
Ultrasharp cantilever/tip (MikroMasch) with a length of 120-130 \xm, a width of 32-38 \xm, a 
thickness of 3.5-4.5 )nm, a resonant frequency of 265-400 kHz, and a spring constant of 20-
75 N/m was used to image the substrates. The setpoint oscillation was set to 80% of the free 
oscillation amplitude and 25 um2 images were recorded at a scan rate of 1.5 Hz. The viruses 
in each topographic image were enumerated manually with a height scale of 20 nm using a 
pen style colony counter (Sigma). 
Data Analysis. Experimental counts of bound PPV/25 um2 were plotted versus the 
substrate rotation rate. The error in the measurements were assumed to follow a Poisson 
distribution predicted by counting statistics49 since the measured error'was smaller than 
predicted, and is represented by the plotted error bars. Equations describing these curves 
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were determined using the curve-fitting software provided with SigmaPlot 8.0, which relies 
on the Marquardt-Levenberg algorithm.50 The fits were performed with the default 
parameters of 100 iterations (maximum), a step size of 100, and a tolerance of 0.0001. The 
curves were fit with weight 1/y2 to account for differences in the uncertainty of each data 
point.49 The coefficient of determination (r2 value) was used to measure the fit of the 
calculated equation to the experimental data. 
Results and Discussion 
The principal goal of this work was to reduce the required incubation time for 
immunoassays by substrate rotation while maintaining satisfactory performance (e.g., 
detection limit). A key step towards achieving this goal is understanding how best to 
implement rotation to control flux. The following sections therefore describe a detailed 
investigation of the relationship between capture substrate rotation rate and incubation time 
on PPV binding. First, experimental results are compared to theoretical predictions in order 
to substantiate the claim of controlled flux. Through curve fitting, it is possible to predict the 
PPV binding results for a given set of experimental conditions as well as extract the absolute 
solution concentration of virus in units of PPV/mL. Finally, the advantages of rotating a 
capture substrate are demonstrated by constructing a dose-response curve with and without 
substrate rotation. 
Control of Antigen Extraction via Substrate Rotation and Incubation Time. 
Capture substrates were exposed to sample solutions of PPV (3.2 x 106 TCIDso/mL) with 
varying rotation rates and incubation times. The substrates were then imaged using AFM to 
visualize and enumerate captured PPV. A 5 x 5 |j,m scan size was selected to image the 
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substrates because it balances the merits of imaging as large of an area as possible, while still 
providing sufficient resolution to confidently identify individual PPV particles when 
collecting 512 data points per line scan. A partial set of the AFM findings is presented in 
Figure 3. As evident, PPV appears as a spherical object with a height of ~18 nm (topography 
cross-sections not shown). The height (z-direction) of the imaged PPV is consistent for all the 
particles but is slightly smaller than expected. This difference is a result from the dehydration 
of the ~25-nm viral particles on the substrate after drying. Note as well that the lateral size of 
the PPV varies in the x-y plane from image to image. This lateral variation is an artifact of tip 
convolution effects51 and the use of different tips to image different samples. Importantly, the 
consistency in height allows for identification and enumeration of captured PPV. 
The AFM images in Figure 3 illustrate the effect of substrate rotation rate and sample 
incubation time on the number of viruses captured. The three images in Figure 3 A present the 
findings for a 10-min incubation in PPV for a stationary capture substrate and for substrates 
rotated at 100 and 400 rpm. Rotation clearly yields a significant increase in the number of 
viruses bound to the substrate. Moreover, a larger rotation rate results in a rise in the number 
of bound viruses. A similar trend is evident in the images in Figure 3B for an incubation time 
of 30 min. Not surprisingly, when comparing images at the two different incubation times but 
same rotation rate, the longer incubation time leads to increased binding. 
Figure 4 plots the observed surface concentration of bound viruses (normalized to an 
area of 25 ^m2) versus rotation rate for both 10- and 30-min incubation times. Rotation rates 
up to 1200 rpm were tested. These plots, as expected, demonstrate that both incubation time 
and rotation rate can be used to control the number of viruses binding to the capture 
substrate. Interestingly, the plots appear to approach different limiting values of rfl. If given 
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sufficient time, both curves would reach the same value for rfl. However, the 30-min 
incubation plot would reach saturation at a slower rotation rate. A more detailed discussion 
of the shape of these profiles is given in the next section. 
Relating TCID50 and Virus Concentration. A fit of the data plotted in Figure 4 to 
Equation 6, in addition to an implicit validation of the boundary conditions imposed for its 
derivation, will allow accurate predictions to be made regarding the impact on the assay with 
respect to changes in incubation time and rotation rate. The first boundary condition, the 
surface is not saturated with captured antigens, is validated by the AFM findings (Figure 3). 
Theoretically, a jamming limit treatment52 indicates that ~3 x 104 PPV can fit in a 25-p.m2 
area. However, as shown by Figure 4, no more than -800 PPV were found in any 5 x 5 fim 
AFM image. The number of captured viruses is therefore only ~ 3 % of that for a saturated 
substrate. The second boundary condition requires that the loss of PPV from solution during 
the incubation step does not alter the bulk virus concentration. To evaluate if this assumption 
holds, a 3.2 x 106 TdD50/mL solution of PPV (1.0 mL) was exposed to a rotating capture 
substrate (1200 rpm) for 10 min. This substrate was then replaced by a second rotating 
capture substrate (1200 rpm) and exposed to the same PPV sample for 10 min. Both 
substrates were then imaged with AFM to determine if the number of captured PPV on the 
second substrate differed from that of the first. A difference would point to a change in the 
bulk concentration of PPV as a consequence of extraction by the first substrate, and 
potentially invalidate the second assumption. A representative AFM image of each substrate 
is given in Figure 5. The first substrate captured 346±8 PPV/25 jim2 and the second substrate 
bound 341±16 PPV/25 |^m2. This result therefore supports the assumption that the bulk PPV 
concentration is not reduced during the time of incubation.53 The third boundary condition, 
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which pertains to the diffusion limited reaction rate for antigen-antibody binding, has been 
shown in multiple studies18"22 and is most likely applicable in our system. As a result of 
validating the first two assumptions, demonstrating a close fit of the two profiles in Figure 4 
to Equation 6 would strongly argue that the third assumption also holds. 
The two sets of experimental data plotted in Figure 4 were fit to Equation 7 by using 
the Marquardt-Levenberg algorithm,50 noting that the a-parameter represents the first term on 
the right side of Equation 6 and the 6-parameter stands for all remaining variables in the 
second term of the same equation. 
Ta=a + ba/2 (7) 
The best fit curves for 10- and 30-min incubation with the sample solutions are given 
by Equations 8 and 9, respectively, 
r a =25 + 9.9©^ (8) 
r 0 = 4 9 + 266>^ (9) 
where rfl is in units of PPV/25 |a.m2 and wis in units of rpm. Importantly, the calculated 
curves reasonably follow the experimental data (r2 = 0.9952 for 10 min, r2 = 0.9873 for 30 
min), confirming the dependence of the bound PPV on the square root of rotation rate. 
Additionally, the best fit determination of parameter b for the 30-min incubation data is 
approximately threefold greater than that for the 10-min incubation; this difference is 
consistent with the value of b being directly proportional to time. The a term, determined 
from the best fits, is proportional to t but contains greater error since it is based only on two 
data points. This portion of the experiment is also complicated by the fact that immersion of 
the substrate disrupts the existence of a quiet solution. Taken together, the fit of the 
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experimental data to Equation 6 strongly supports the validity of the third boundary condition 
which stipulates that the rate of the binding reaction must be mass transfer limited for the 
range of applied rotation rates. These results provide yet another example of a heterogeneous 
immunoassay that is controlled by mass transfer rather than the rate of antibody-antigen 
recognition. 
The strong correlation between the experimental data and best fit curves provides an 
alternative means for a determination of the relationship between the infective titration 
parameter (TCIDso/mL) and absolute PPV concentration (PPV/mL) by evaluating the second 
term in Equation 6. All of the parameters in the second term, with the exception of Q, 
(PPV/mL), are known and the b value (Equation 7) is measured for both 10- and 30-min 
incubations. For the system presented, Da is 1.75 x 10~7 cm2/s (estimated using a hydrated 
radius of 12.5 nm via the Stokes-Einstein equation54), Fis 1.004 x 10~2 cm2/s at 25°C, and t is 
10 or 30 min. Evaluation of Equation 6, in light of the known parameters and the 
experimentally determined value of b, yields a bulk concentration of PPV of 4.3 x 109 and 
4.9 x 109 PPV/mL for the 30 and 10 min incubation time plots, respectively. 
As a means to validate the PPV concentration determined from the rotation study, 
experiments using exhaustive binding of PPV from a known sample volume to capture 
substrates were performed. These studies exposed a small volume sample of PPV (20 f^ L) to 
a capture substrate. After ~12 h of incubation under stagnant conditions, the sample solution 
was carefully removed from the substrate and dispensed onto a second substrate for another 
12-h incubation. This process was repeated five times using five fresh capture substrates. All 
substrates were then imaged and the number of viruses bound in a 25-um2 area for five 
different locations on each sample was enumerated. The average number of PPV bound in 
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the imaged area was then extrapolated to delineate the number bound in the entire 4.0-mm 
diameter address on the capture substrate. The results from each substrate were added to 
determine the total number of PPV present in the 20 uL of sample solution. 
This experiment was performed twice. The first attempt, as shown by the set of AFM 
images in Figure 6, yielded 187±15 PPV/25 urn2 on the first substrate, 3±1 PPV/25 | W on 
the second substrate, and no detectable PPV on all subsequent substrates. The second study 
captured 177±15 PPV/25 \xm2 on the first substrate, 6±2 PPV/25 ^m2 on the second 
substrate, and no detectable PPV on all subsequent substrates. The two exhaustive binding 
studies yielded PPV concentrations of 4.4±0.4 x 109 and 4.7±0.4 x 109 PPV/mL. These 
results are remarkably similar to the values of Cb calculated from the rotating substrate study, 
substantiating that the substrate rotation technique can be used as an absolute method for 
virus concentration determination. 
The results from the substrate rotation study and exhaustive binding study indicate 
that the PPV concentration is between 4.3 x 109 and 4.9 x 109 PPV/mL. Since the specified 
concentration of PPV equaled 3.2 x 106 TdD50/mL, 1 TCID5o/mL corresponds to 1300 to 
1500 viruses/mL for PPV. TCID50 is a measure of virus concentration based on the 
cytopathogenicity of a virus. However, different viruses have different inherent abilities 
infect and kill cells, and therefore the number of viruses that will cause cell death is specific 
for each virus.33 Thus, the numerical quantities of two different viruses can not be directly 
correlated by using values of TCIDso/mL and a comparison of analytical figures of merit 
between methodologies is difficult unless the same virus is used. We believe that the above 
approach, which establishes the first conversion (to our knowledge) between the quantal 
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numeric of infective dose units and viral concentration in units of viruses/mL for PPV, will 
serve as a much needed means to broadly perform such determinations. 
Dose-Response Curves and Reductions in Incubation Time. Dose-response curves 
were constructed by exposing capture substrates to varying concentrations of PPV diluted in 
10 mM PBS. Two sets of PPV binding experiments were carried out: one without substrate 
rotation and the other while the substrate was rotated at 800 rpm. All incubation times were 
held constant at 10 min, with the number of PPV bound to each substrate enumerated by 
AFM. Figure 7 plots the results of this study. 
As is evident, the immunoassay performed with substrate rotation is much more 
sensitive than that relying solely on analyte diffusion. Only a few virus-sized objects are 
found in the 25-jim2 images of blanks. The low responses from the blanks, which is expected 
in view of the use of purified antigen solutions and monoclonal antibodies, are attributed to 
debris with a size comparable to PPV and/or to a small amount of contamination from 
transfer pipettes. Based on these results, the limit of detection, which is defined as the 
concentration yielding a signal equal to the blank signal plus three times its standard 
deviation, is 3.2 x 105 TCIDso/mL without rotation and 3.4 x 104 TCIDso/mL with rotation at 
800 rpm. If we use the average of the two conversion factors determined earlier, these results 
correspond to a limit of detection of 4.9 x 107PPV/mL (-80 fM) with rotation and 
4.6 x 108 PPV/mL (-800 fM) without rotation. 
There is one other interesting, but not yet understood, observation from the plots in 
Figure 7. The response is linear for the immunoassay performed without rotation throughout 
the concentration range tested, while that with rotation is linear in the lower concentration 
range but begins to negatively deviate at high concentrations. Linearity is expected in both 
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cases in accordance with Equation 6, and we are currently working to identify experiments 
that may provide insight into the observed deviation. 
Finally, the overall approach to this assay has a strongly predictive value in that the 
experimental conditions can be tailored via Equation 6 to obtain the desired result. If, for 
example, all the known parameters for the PPV assay are incorporated into Equation 6, we 
can write, 
Tfl = c / l . 6x10-9 ft +2.0x1 ( T 1 0 ^ ] (10) 
where rfl is in PPV/25 um2, / is in minutes, Cb is in PPV/mL, and &>is in rpm. Equation 10 
provides the flexibility to calculate: (1) the necessary rotation rate to detect a given Cb in a 
predetermined incubation time; (2) the limit of detection, Cb, at a fixed rotation rate and 
incubation time; or (3) the time required to detect a desired Cb with a set rotation rate. We 
believe that the predictive nature of this system is on par with the importance of its ability to 
convert from TCIDso/mL to PPV/mL and to rapidly detect exceedingly low levels of PPV. 
Conclusions 
Substrate rotation can be used to increase antigen flux to the capture surface in a 
heterogeneous immunoassay. The flux of the antigen can be controlled and employed to 
predict and design optimized immunoassays. Substrate rotation led to an improvement in the 
analytical performance of the presented AFM-based immunoassay as well as a decrease in 
incubation times. Additionally, due to the predictive nature of the system, it was possible to 
determine the concentration of PPV in an unknown sample solution without the use of 
standards and to develop an approach to convert quantal metrics to actual antigen 
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concentrations. Experiments to apply this concept to more challenging sample types and 
matrices are planned. 
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Figure Captions 
Figure 1. Calculated antigen surface concentration accumulated as a function of time, 
antigen diffusion coefficient, and substrate rotation. 
Figure 2. Schematic of solution flow in the presence of a rotating capture rod. 
Figure 3. AFM micrographs (5x5 urn) of PPV bound to capture substrates with an 
incubation time of (A) 10 and (B) 30 min. The capture substrate was either held stationary, or 
rotated at 100 or 400 rpm. 
Figure 4. The number of PPV bound to the capture substrates at varying rotation rates is 
plotted. Each plot is constructed from the average of 2-3 substrates at each rotation rate. Five 
AFM images from each capture substrate were then collected. The error bars represent the 
error introduced using Poisson statistics and the solid lines are weighted fits of the 
experimental data to Equation 7 (see text for details on data analysis). 
Figure 5. AFM micrographs of successive exposure of two capture substrates (1200 rpm, 
10 min incubation) to the same 3.2 x 106 HA/mL PPV sample solution. The first substrate 
(left) was exposed to the original sample and captured 346±8 PPV/25 (im2. The second 
substrate (right) was exposed to the same PPV sample solution and bound 
341±16 PPV/25 |im2. 
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Figure 6. Exhaustive binding of 20 uL of PPV (3.2 x 106 HA/mL). The same sample was 
exposed to substrate A for ~12 h followed by subsequent exposure to substrate B and C for 
-12 h each under stagnant conditions. 
Figure 7. Dose-response curves for immunoassays performed under stagnant conditions and 
with capture substrate rotation at 800 rpm. The sample volume was 1.0 mL and the 
incubation time was 10 min. Each data point is the average signal measured from five 
different locations on the same sample substrate and the standard deviations are represented 
by the error bars. 
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Abstract 
A rapid, sensitive immunosorbent assay has been developed to meet the increasing 
demands in the medical and bioterrorism prevention arenas. The immunoassay couples the 
specificity of antibody-antigen interactions with the ultra-high sensitivity of surface-
enhanced Raman scattering detection in a sandwich format. As a means to overcome the long 
incubation times often required for heterogeneous immunoassays, this paper introduces the 
concept of a rotating capture substrate to increase antigen and label flux to the solid phase 
surface, thereby reducing assay times. To investigate this strategy, polyclonal anti-rabbit IgG 
was immobilized on a gold capture substrate via a thiolate coupling agent. The capture 
substrate, capable of controlled rotation, was then immersed in a sample solution containing 
rabbit IgG, which served as a model analyte. After binding the target IgG, the substrates were 
immersed and rotated in an extrinsic Raman label (ERL) labeling solution, which is 
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composed of gold nanoparticles (60 nm) coated with an aromatic moiety as the Raman 
scatterer and an antibody as the biospecific recognition element. The effect of substrate 
rotation on both the antigen binding and ERL labeling steps was investigated. 
Implementation of optimized rotation conditions resulted in the reduction of assay times from 
24 h to 25 min and a tenfold improvement in the limit of detection. The developed protocol 
was also applied to the detection of rabbit IgG suspended in goat serum, which served for 
assessment of performance in a biological matrix. 
Introduction 
Immunoassays have an important niche in the diagnostic laboratories of human and 
veterinary medicine and in efforts focused on bioterrorism prevention.1"4 Even with the 
success and widespread use of these tests, improvements in sensitivity, specificity, speed, 
cost, and throughput are continuously sought to meet increasingly stringent demands. This 
paper seeks to provide improvements in the sensitivity and speed offered by many of the 
methodologies for heterogeneous assays. 
Heterogeneous immunoassays require the delivery of antigen to a solid capture 
substrate, and typically rely solely on diffusion as the mode of mass transport. The challenge 
with such systems, however, is that long incubation times are required because large 
biological targets (e.g., proteins, viruses, and bacteria) have small diffusion coefficients.5 
This limitation is amplified for sandwich-type assays since a diffusion-based labeling step 
that utilizes a tagged antibody is needed in order to identify and quantify the surface-bound 
antigen. 
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Along these lines, a number of approaches have been investigated to increase the flux 
of the antigen or label as a means to reduce incubations times, capitalizing on the fact that 
antibody-antigen binding is often limited by mass transport rather than by binding kinetics 
(i.e., recognition rate).6"10 Electric fields, for example, have been used to drive the transport 
of charged species, and have been employed to reduce the binding time for DNA 
hybridization assays1' as well as for proteins in heterogeneous immunoassays to only a few 
minutes.12 Paramagnetic labels have also been shown to bind to surface-bound antigen in a 
solid-phase immunoassay in less than 3 min using a magnetic field to aid in transport, 
whereas overnight incubations were required in the absence of a magnetic field.13 In addition, 
the confinement of flowing sample solution to a thin layer above a capture antibody substrate 
has been found to decrease the binding time to 25% of that required for static incubation.14 
Another report has demonstrated that an equivalent level of antigen binding can be achieved 
in less time for assays conducted at elevated temperatures as compared to room 
temperature.15 
Rotation, the focus of this paper, is an established method for controlling flux to a 
surface, and has long been exploited in investigations of electrochemical mechanisms by 
manipulation of the rate of mass transport.16"18 We recently reported on an extension of this 
concept by introducing capture substrate rotation as a means to controllably increase antigen 
flux and therefore markedly reduce binding time.19 That work utilized substrate rotation only 
in the antigen binding step. It also relied on atomic force microscopy for the direct 
enumeration of captured viruses, a readout technique that is more readily adaptable to 
imaging objects the size of viruses but not proteins.20"24 In this earlier report, we showed that 
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the accumulation of bound antigen, represented by its surface concentration Ta, during this 
first step is given by19 
n
 \.6\VA 
where D is the antigen diffusion coefficient, Cb is the bulk concentration of the antigen, / is 
the incubation time, Vis kinematic viscosity of the solution, and a>\s the rotation rate. The 
first term on the right hand side of the equation represents the contribution of diffusional 
mass transfer, whereas the second term defines the role of substrate rotation. Equation 1 
explicitly shows that antigen binding can be manipulated by varying t and a. 
There are a few precedents on the use of rotation in sandwich-type heterogeneous 
immunoassays. " Earlier work used rotation as an effective means to control antigen flux 
to a capture substrate, targeting the development of an assay that was independent of sample 
volume rather than enhancements in mass transfer. Other laboratories took a different tactic 
by employing rotation during the amperometric detection step of an enzymatically generated 
redox probe.26"28 The work herein describes a rotation-based method designed to reduce both 
the antigen and label binding times that can be universally applied to any sandwich-type 
immunoassay. 
A plethora of readout methods have been created for heterogeneous immunoassays. 
More routine techniques for quantification include scintillation counting, fluorescence, 
chemiluminescence,33 electrochemical,34 and enzymatic methods.2'35 Other strategies, such 
as surface plasmon resonance,36"41 surface-enhanced Raman scattering,35'42"56 quantum 
dots,57"60 and microcantilevers,61'62 have shown great promise for increasing throughput and 
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improving sensitivity, but are in earlier stages of development. Again, we believe that the 
approach detailed in this report can be readily adapted for use with all of these techniques. 
As a proving ground for the merits of rotation in a sandwich immunoassay, this paper 
utilizes a SERS-based labeling scheme previously developed in our laboratory for readout.44" 
46
 Our approach employs extrinsic Raman labels (ERLs) to identify and quantify antigens in 
a sandwich immunoassay format. ERLs consist of gold nanoparticles coated with an 
intrinsically strong Raman scatterer as the spectroscopic tag and an antibody as the molecular 
recognition element. Previous studies resulted in the detection of as few as -60 binding 
events using 30-nm-diameter gold nanoparticles, which for an assay of prostate specific 
antigen in human serum yielded a limit of detection of ~30 fM. 45 We more recently 
demonstrated the detection of single-digit binding events with the use of larger nanoparticles 
as a means to optimize surface plasmon coupling with the underlying gold substrate at the 
wavelength of the excitation source.63 
While this intriguing readout strategy is proving to be extremely sensitive, there are 
several challenges to advancing its range and scope. One of the major obstacles rests with the 
long incubation times required by both the antigen-capture and -labeling steps, which 
becomes even more acute upon recognition that the large size and mass of the ERLs translate 
to even lower levels of diffusional mass transfer than the more typical labels (e.g., 
fluorescently or enzymatically tagged antibodies) in a sandwich-type assay. An estimate 
based only on particle size via the Stokes-Einstein equation64 yields a diffusion coefficient 
for an ERL with a 60-nm gold core which is roughly tenfold smaller than that of a 
fluorescently labeled antibody. The labeling step with ERLs is therefore five times slower 
than that for a fluorescently tagged antibody.65 By capitalizing on the second term in 
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Equation 1, it is possible to improve flux via substrate rotation in order to overcome 
diffusional limitations in both the antigen-capture and -labeling step imposed by small 
diffusion coefficients. 
A general schematic of the assay is presented in Figure 1. One end of a rotating rod is 
coated with gold and modified with dithiobis(succinimidyl propionate) (DSP). Next, an 
antibody, which for the purposes of this work is anti-rabbit IgG, is covalently immobilized 
onto the surface via succinimidyl ester chemistry to the DSP-modified surface and the 
resulting capture surface is lowered into a sample solution. The rod is then rotated at a 
controlled rate, and if present, rabbit IgG is extracted onto the capture substrate. After a 
rinsing step, the capture substrate is subsequently immersed in a solution of ERLs and again 
rotated at a controlled rate. The analyte, rabbit IgG, is subsequently quantified by the spectral 
intensity of the Raman scatterer used to prepare the ERLs. 
The goal of this work is to show that, like the antigen capture step, the ERL labeling 
step is also governed by Equation 1, and that rotation is applicable to assays carried out in a 
representative biological matrix (i.e., goat serum) as an effective means of reducing the 
binding time. The following sections detail studies on the effect of capture substrate rotation 
with respect to the antigen and ERL binding time and the limit of detection. We conclude 
with the implementation of rotation in an assay for rabbit IgG from goat serum in which the 
assay time is reduced from -24 h to -25 min and the limit of detection is improved by a 
factor often compared to the assay performed under static conditions. 
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Experimental 
Reagents. Gold nanoparticles [60-nm diameter (<8% variation in diameter), 2.6 x 
1010 particles/mL] were purchased from Ted Pella. Octadecanethiol (ODT), 
dithiobis(succinimidyl propionate) (DSP), and phosphate buffered saline (PBS) packs 
(10 mM, pH 7.2) were attained from Sigma. SuperBlock and BupH Borate Buffer Packs (50 
mM, pH 8.5) were obtained from Pierce. The synthesis of DSNB was achieved following a 
previously published procedure.45 All buffers were purified by passage through a 0.22-|im 
syringe filter (Costar). Contrad 70 (Decon Labs), a mild detergent, was used to clean the 
glass substrates. Poly(dimethyl siloxane) (PDMS) was acquired from Dow Corning and used 
to fabricate microcontact printing stamps. 
Goat anti-rabbit IgG polyclonal antibody was purchased from US Biological. The 
antibody was purified by immunoaffinity chromatography and supplied as 0.5 mg/mL in PBS 
(pH 7.2) containing 0.01% sodium azide and 40% glycerol. Experiments show that the 
performance of the assay varies slightly with each batch of the antibody. Whole molecule 
rabbit IgG, also acquired from US Biological, was purified by Protein A affinity 
chromatography and stored at 10 mg/mL in PBS (pH 7.2). Unless otherwise noted, rabbit 
IgG was diluted with 10 mM PBS. Normal goat serum was obtained from Pierce and, where 
noted, served as a representative biological matrix for rabbit IgG dilution. This serum has a 
protein concentration of 60 mg/mL and a pH of 7.2. 
ERL Preparation. ERLs are designed to provide a strong Raman signal and selective 
recognition by, in this case, immunospecificity. As such, DSNB was chosen as the Raman 
reporter molecule because of the intrinsically strong Raman scattering cross section of its 
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symmetric nitro stretch, its ability to chemisorb to gold nanoparticles through its disulfide 
moiety, and its capacity to covalently conjugate antibodies via its succinimidyl ester. This 
design minimizes the distance between the Raman scatterer and the nanoparticle, yielding a 
large surface enhancement. This component of the label design is of particular importance 
because recent reports have proposed that enhancements undergo a sharp decrease {d "12)66 as 
the distance (d) between the particle surface and scattering mode increases. 
The ERLs are constructed by first adjusting the pH of a 1.0-mL suspension of 60-nm 
colloidal gold to 8.5 by adding 40.0 ^L of 50 mM borate buffer. This pH was chosen to 
deprotonate the amines of the antibody added in subsequent steps, which promotes the 
reaction with the succinimidyl ester of DSNB and stabilizes the nanoparticle suspension upon 
conjugation with the antibody. Next, 10.0 uL of 1-mM DSNB, dissolved in acetonitrile, was 
added to the nanoparticle suspension and mixed for ~12 h to form a DSNB-derived coating 
on the gold surface. This step was followed by the addition of 20 (ig of antibody (40.0 uL at 
0.5 mg/mL) to the colloidal suspension. The antibody was reacted for ~8 h with the DSNB-
modified nanoparticles. As detailed previously,46 this concentration of antibody was 
necessary to fully coat the nanoparticles and maintain a stable suspension upon the addition 
of salt. 
To block any unreacted succinimidyl ester groups, 100 (aL of 10% BSA in 2 mM 
borate buffer was added to the nanoparticle solution for -12 h. To remove excess DSNB, 
antibody, and other residual materials, the suspension was then centrifuged at 2000g for 10 
min. After decanting the supernatant, the nanoparticles were resusupended in 1.0 mL of 2 
mM borate buffer containing 1% BSA. This washing cycle was repeated twice to thoroughly 
clean the suspension. To achieve physiological conditions, concentrated NaCl was added to 
160 
the ERLs to yield a final salt concentration of 150 mM. As a final step, the suspension was 
passed through a 0.22-[im syringe filter to remove any large aggregates. 
Capture Substrate Preparation. Glass microscope slides (Fisher Scientific) were 
cut into 1 x 1 cm squares, and ultrasonically bathed in 10% Contrad 70, deionized water, and 
ethanol, each for 30 min. The glass was dried and 15 nm of chromium and 250 nm of gold 
were resistively evaporated onto the glass chips with an Edwards 3 06A evaporator, both at a 
rate of 0.1 nm/s at a chamber pressure less than 7.5 x 10"7 Torr. Upon removal from the 
evaporator, each substrate was addressed by exposure for ~30 s to an ODT-saturated PDMS 
stamp that had a 4.0-mm hole cut in its center. The substrates were then rinsed with ethanol 
and dried with a stream of high-purity nitrogen. This stamping procedure is a convenient 
method of forming a hydrophobic barrier on the outer portion of the substrate that defines a 
sample address as a means to localize aqueous reagents in the center of the substrate and 
minimize sample and label consumption. Next, the substrates were immersed in a 0.1 mM 
ethanolic solution of DSP for 8 h in order to form a DSP-derived monolayer on the gold 
portion of the substrate not inked with ODT. The substrates were then removed from the DSP 
solution, rinsed with ethanol, and dried with a stream of high-purity nitrogen. 
Anti-rabbit IgG was immobilized on the substrates by pipetting 20.0 \xL of 
100 p.g/mL solution of the antibody (diluted in 50 mM borate buffer) onto the DSP-modified 
region. After allowing 8 h for antibody coupling,21'67'68 the substrates were rinsed three times 
with 2 mL of 10 mM PBS. The construction of the capture antibody substrates was 
completed by pipetting SuperBlock blocking buffer (20.0 \xL) onto the capture substrate in 
order to block any unreacted succinimidyl ester. The capture substrates were then rinsed with 
10 mM PBS after 12 h of exposure to the blocking buffer.46 
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Immunoassay Protocol. The capture substrates were exposed to sample solutions 
(PBS or goat serum) containing varied levels of rabbit IgG. The assays performed under 
stagnant conditions (i.e., no rotation) exposed 20.0 uL of sample to the capture substrate for 
10 min or 12 h in a humidity chamber. Assays in which the capture substrate was rotated 
(800 rpm) required 1.5 mL of sample to effectively submerge the substrate and permit 
controlled stirring; these assays employed a 10-min incubation time. 
After incubation, all samples were rinsed three times in 2 mL of 2 mM borate buffer 
(pH 8.5) containing 1% BSA and 150 mM NaCl. The capture substrates were then exposed 
to 20.0 \iL of ERLs for 10 min or 12 h without rotation or 1.5 mL of ERLs for 10 or 15 min 
with rotation at either 800 or 1200 rpm. After incubation, the substrates were rinsed with 2 
mM borate buffer (1% BSA, 150 mM NaCl, pH 8.5) and dried under a stream of high-purity 
nitrogen. The SERS spectra were then collected. 
Instrumentation, (i) Rotator and Rotating Rod. The capture substrate, as prepared 
above, is attached to the end of a 17-cm stainless steel rod by double sided tape (3M). The 
diameter of the rod is 6 mm, which readily mates with an AFMSRX rotator (Pine Instrument 
Company). The substrate is then lowered into a sample or labeling well (17-mm diameter) 
and rotated at a controlled rate with the AFMSRX analytical rotator. The rotator has an 
accuracy of 1% between 0 and 10,000 rpm. The slew rate of the motor is -300,000 rpm/s; 
therefore, the desired rotation rate is effectively attained instantaneously for the rotation rates 
(800 or 1200 rpm) and incubation times (10 or 15 min) used in these experiments. 
(ii) SERS Measurements. Raman spectra were collected with a NanoRaman I 
(Concurrent Analytical) fiber-optic Raman system. The excitation source is a 30-mW, 632.8-
nm He-Ne laser. The spectrograph consists of an f/2.0 Czerny-Turner imaging spectrometer 
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(resolution of 6-8 cm"1) and a thermoelectrically cooled (0°C) CCD (Kodak 0401E). The 
probe objective (numerical aperture 0.68) focuses the laser to a 25-[im diameter spot on the 
substrate surface. The same objective is used to collect the scattered Raman radiation. All 
spectra were acquired with a 1-s integration time. 
Results and Discussion 
Control Studies. Initial experiments to detect rabbit IgG using the SERS-based 
assays were performed by following our earlier protocol, which serve as a comparative 
standard46 and a control in each experiment to account for differences in performance due to 
variations with different batches of vendor supplied antibodies. This comparative protocol 
called for a 12-h incubation of the capture substrate with a 20.0 |a.L sample of rabbit IgG, 
followed by a 12-h incubation in 20.0 uL of the ERL labeling solution. Both steps were 
performed in stagnant solution. The Raman spectra for varied concentrations of rabbit IgG, 
including a blank solution, are presented in Figure 2. All these spectra contain features 
characteristic of the DSNB-based Raman reporter molecule, and are diagnostic of the 
presence of the DSNB-modified ERLs.45 The dominant feature in the spectra is the 
symmetric nitro stretch (v^(N02)) at 1336 cm"1, which will be used for quantification of assay 
performance. Other prominent features include the nitro scissoring vibration at 851 cm"1, an 
aromatic ring mode at 1566 cm"1, and a succinimidyl N-C-0 stretch that overlaps with other 
aromatic ring modes at 1079 cm"1. 
Figure 2 also shows that the intensity of the Raman spectra varies proportionally with 
the concentration of rabbit IgG. This dependence is summarized by a plot of the intensity of 
v.s(N02) versus the rabbit IgG concentration to yield one of the two dose-response curves 
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shown in Figure 3. Each data point is the mean intensity of v$(N02) measured from five 
locations on a single sample and the error bars represent the standard deviation in signal. 
Sample-to-sample variations were less than 10%. As is evident from the spectrum in Figure 
2, there is a small but readily detectable signal for the blank resulting from nonspecific 
binding of the ERLs. Moreover, the response of the blank is slightly less than that for the 1 
ng/mL sample, demonstrating the limitation on detection is dictated by nonspecific 
adsorption. Formally, the limit of detection, which is defined as the concentration which 
results in a signal equal to that of the blank plus three times its standard deviation, is ~1 
ng/mL. 
To demonstrate the importance of incubation time on assay performance, an 
immunoassay for rabbit IgG was performed under static conditions allowing the substrate to 
incubate with the sample for only 10 min and the ERL solutions for only 10 min. Although 
not shown, the spectroscopic intensities are much weaker than those obtained for the 12-h 
incubations. The resulting dose-response curve is also shown in Figure 3. An antigen 
concentration dependent response is observed, however, compared to the assay with 12-h 
incubations the sensitivity is markedly decreased. While the signals for specific binding are 
significantly reduced for short ERL incubation times, importantly, the nonspecific binding 
also decreases. Thus, there is only a tenfold loss in the limit of detection with the shorter 
binding times. Other studies (data not shown) have concluded that for these incubation times, 
equilibration is not reached; these combined data emphasize the importance of incubation 
time and the need for increasing antigen and label flux to the sample surface. 
In an effort to shorten the time required for the immunoassay, the influence of 
substrate rotation on the antigen binding step was investigated. To test this, an immunoassay 
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was performed in which the capture substrate was rotated at 800 rpm for 10 min in the 
sample solution. According to Equation 1, these conditions result in a fivefold increase in 
impingement (1.9 x 1011 IgG/cm2) compared to that under stagnant binding (3.7 x 1010 
IgG/cm2). Following sample extraction, ERLs were allowed to react with the samples for 12 
h in quiet solution. Due to lower ERL concentrations and a smaller value for D, ERL 
impingement is estimated to be only 1.8 x 109 ERL/cm2. Based on these calculations, and the 
fact that equilibrium is approached but not achieved, labeling is the limiting step and it is 
expected that results will be similar to those of the comparative assay. Thus, any changes in 
the resulting spectral intensities would be a direct result of an ineffective antigen binding 
step. The dose-response curve for this assay is shown in Figure 4, along with the results for 
the control assay (i.e., no rotation). Analysis of the dose-response curves reveals that no 
significant changes in the intensities occur as a result of substrate rotation during the sample 
incubation step; thus, rotation-induced flux is an effective means of ERL delivery. This assay 
also resulted in a detection limit of ~1 ng/mL. Therefore, the time required to detect rabbit 
IgG can be reduced from ~24 to ~12 h without a loss in the limit of detection simply by 
implementing rotation to increase antigen flux to the capture surface. 
Rotation Studies. Similar studies were performed to investigate the effect of 
substrate rotation on ERL binding. Two conditions were tested; first, rabbit IgG was allowed 
to bind to the capture substrate for 12 h without rotation prior to capture substrate rotation at 
800 rpm for 10 min in an ERL solution. The second assay utilized substrate rotation (800 
rpm, 10 min) to capture the antigen and was followed by rotation (800 rpm, 10 min) in ERLs. 
It was hypothesized that the results of these assays should be similar since the previous study 
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showed that the signal is dictated by the labeling step. The dose-response curves obtained 
under these conditions are given in Figure 5, along with a control curve for comparison. 
Several important conclusions can be drawn from these experiments. First, as 
predicted, equivalent dose-response curves can be constructed with substrate rotation in the 
labeling solution regardless of the manner in which the antigen is bound. This provides 
further support for the conclusion drawn from the first set of experiments studying the 
influence of rotation on antigen binding. The second noteworthy observation from Figure 5 is 
that smaller signals are obtained when ERLs bind under the rotation conditions selected. 
However, first approximations via Equation 1 estimate the ERL impingement to be three 
times greater than ERL labeling in quiet solution. Additionally, the nonspecific binding of 
the ERLs is significantly lower for the assays utilizing rotation to bind the label. In fact, the 
blank signal due to nonspecific binding diminishes disproportionately to the decrease in 
specific binding as a result of substrate rotation, and a detection limit of ~1 ng/mL was 
obtained for these assays as well. The origin of this disproportional binding is speculated to 
result from additional forces imposed by rotation that remove nonspecifically bound ERLs, 
and studies are in progress to understand and capitalize on this finding to further lower the 
levels of detection. 
There are several possible origins for the decreased specific ERL binding when 
rotation is employed. One possibility is that harsher conditions imposed during rotation in the 
ERLs, compared to stagnant conditions, removes bound antigen from the capture substrate. 
Another potential reason is that the rotation rate and incubation time under which these ERL 
incubations were performed are not delivering as many labels to the surface as can be 
achieved via diffusion for 12 h, contrary to initial projections (i.e., rfl in Equation 1 may be 
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lower than predicted). The value for D of the ERL was crudely approximated by the Stokes-
Einstein equation64 in which mass in not a factor and radius is difficult to predict. 
Additionally, Cb was taken to be that provided by the vendor, but it is qualitatively known 
that some of the labels are lost during the centrifugation/resuspension cleaning steps, which 
would serve to lower C&. Thus, it is probable that D is much smaller than estimated. 
Collectively, these details explain any discrepancies that yield an overestimation of ERL 
impingement. 
To test the effect of substrate rotation on bound antigen, several capture substrates 
were prepared and each exposed to 100 ng/mL rabbit IgG (20.0 fjL) for 12 h. One substrate 
was subsequently exposed to 20.0 uL of ERLs for 12 h under stagnant conditions while 
another was rotated at 800 rpm for 10 min in ERLs to serve as controls. A third substrate was 
rotated in 2 raM borate buffer (1% BSA, 150 mM) at 800 rpm for 10 min, to mimic rotation 
in ERLs, and then exposed to 20 uL of ERLs without rotation. Blank studies were also 
performed under each of these conditions. The resulting SERS signals are shown in Figure 6. 
The signal obtained for the capture substrate rotated in buffer prior to labeling with 
ERLs under static conditions was similar to that for the substrate labeled without rotation. 
Moreover, the substrate exposed to ERLs with rotation gave a less intense signal. These data 
suggest that the bound antigen is unaffected by solution flow during a rotation step and 
another mechanism is responsible for the lower signal observed when labeling is performed 
with substrate rotation. It is also important to note that the blank signals in these assays are 
consistent with previous results, and much less nonspecific binding arises as a result of 
rotation in the labeling solution. 
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The rotation rate was increased and the incubation time was lengthened to increase 
the impingement of the ERLs on the substrate in an effort to reach the signals achieved 
without rotation. Substrates exposed to 100 ng/mL rabbit IgG (20 uL) for 12 h were then 
incubated with ERLs for 12 h under stagnant conditions, or rotated in an ERL solution for 10 
min at 800 rpm, 10 min at 1200 rpm, or 15 min at 800 rpm. Control substrates were exposed 
to 10 mM PBS in place of the rabbit IgG and then incubated with ERLs under the conditions 
outlined above. The measured intensities of the symmetric nitro stretch for each substrate are 
plotted in Figure 7. While this set of experiments was performed with a new batch of 
antibodies and the signal for the 100 ng/mL control (i.e., stagnant incubation) is lower than 
that obtained in earlier studies, as is evident, the signal obtained for the 100 ng/mL sample of 
IgG increases as the rotation rate increases from 800 to 1200 rpm and as the incubation time 
increases from 10 to 15 min. This discrepancy in signal from earlier studies is attributed to 
differences in antibody performance. 
Detailed analysis of these results supports the hypothesis that lower signals are 
recorded for ERL labeling with rotation as a result of fewer labels impinging the surface as 
compared to labeling under stagnant conditions for 12 h. First, rotation-induced flux, and 
therefore Ta, is directly proportional to time while it is only proportional to the square root of 
rotation rate. Thus, the signal is expected to increase more for a 50% increase in incubation 
time compared to a 50% increase in rotation rate. This general trend was experimentally 
followed, however, at 1200 rpm vortexing of the ERL solution resulted from the 
experimental setup. Therefore, a more detailed quantitative analysis was not possible since 
the non-laminar flow profile is not accounted for in the rotation-induced flux theory. 
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Nevertheless, these data support the conclusion that ERL impingement is governed by 
Equation 1. 
This reasoning suggests that it is possible to reach the signal levels achieved without 
rotation by increasing the impingement of the ERLs on the substrate. Per Equation 1, 
increases can be realized by further increasing the rotation rate, the incubation time, the ERL 
concentration, or any combination of these. Evaluation of the blank signal in Figure 7 also 
shows that the nonspecific binding is still lower than with diffusion as long as labeling is 
performed with rotation regardless of rotation rate or incubation time. Therefore, the limit of 
detection could be tremendously improved compared to the control assay while reducing the 
assay time from ~24 h to ~ 30 min. 
An optimized assay was performed by identifying an appropriate rotation rate, 
incubation time, and ERL concentration and evaluated against a control assay. A rotation rate 
of 800 rpm was selected to maintain laminar conditions and the incubation time was held at 
15 min. Larger signals could be realized with a longer incubation time; however, in light of 
the overall goal of decreasing the assay time, other means of obtaining signal equivalent to 
the control assay is preferred. Therefore, the concentration of ERLs was increased from 5.2 x 
1010 ERLs/mL, the concentration used in the control assays, to 10.4 x 1010 ERLs/mL in an 
effort to increase the number of labels impinging the surface-bound antigen. The results of 
this assay, and those of a control assay, are shown in Figure 8. 
There are several noteworthy observations from the two curves. First, at the higher 
concentrations tested, larger signals are obtained for substrates rotated in the ERL labeling 
solution. For the assay without rotation in ERLs, fewer labels impinge the surface to tag the 
bound antigens. Rotation increases the number of ERLs impinging the surface and therefore 
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leads to higher SERS intensities. At the lower range of rabbit IgG concentrations, similar 
signals are observed for the case of static and convective labeling. Both of these conditions 
result in excess ERLs impinging the surface and fully labeling the captured antigen. Lastly, 
less nonspecific binding occurs for the substrates that are rotated in the ERL solution. This 
results in a detection limit of ~10 ng/mL for the assay without rotation and ~1 ng/mL for the 
assay performed with rotation. The detection limits were found to vary for each batch of 
antibody received from the vendor, but this tenfold improvement in detection limit was 
consistent. 
Biological Matrix. Detection of a protein in a PBS matrix is only realistic if the 
sample has been heavily purified. Ideally, an assay for a protein could be performed directly 
on a blood serum sample, which contains large levels of nontargeted proteins that may 
degrade performance because of nonspecific adsorption. Therefore, an assay for rabbit IgG 
suspended in goat serum was performed in order to mimic a biological matrix. Following the 
standard assay protocol, sample substrates were exposed to either 20.0 uL of 100 ng/mL 
rabbit IgG diluted in goat serum or 20.0 |jL of blank goat serum for 12 h followed by 
incubation with 20.0 \xL of ERLs (5.2 x 1010 ERLs/mL) for 12 h. For comparison, capture 
substrates were rotated at 800 rpm for 10 min in the serum-based sample and blank solutions 
and then rotated at 800 rpm for 15 min in ERLs (10.4 x 1010 ERLs/mL). 
The results are presented in Figure 9. Similar signals were obtained for the 100 
ng/mL samples diluted in goat serum and for the 100 ng/mL samples diluted in a clean PBS 
solution. Like the assay in PBS, the signal for the rotated sample is slightly larger than that 
for the sample statically incubated. The nonspecific binding is again found to be less for the 
rotated sample, however, the serum blank yields a larger amount of nonspecific binding than 
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the PBS blank, which results in a detection limit for rabbit IgG in a serum matrix of 
~10 ng/mL with rotation and -30 ng/mL without rotation. While preliminary in that more 
effort could be placed on finding a more effective blocking agent, these data demonstrate that 
substrate rotation can be successfully applied to real sample matrices for the reduction of 
assay time and lowering of detection limit. 
Conclusions 
This is the first report on the combination of rotation-induced flux and SERS readout 
in a sandwich-type immunoassay format. Systematic studies of the influence of rotation on 
antigen and label binding led to an optimized immunoassay yielding a tenfold decrease in the 
limit of detection (i.e., ~10 ng/mL to ~1 ng/mL) and a reduction in the assay time from 24 h 
to 25 min compared to a static immunoassay. Additionally, rotation-induced flux was 
effectively applied to samples in a serum matrix. We are beginning further investigation into 
the mechanism of nonspecific binding. We found that labeling under convective conditions 
reduces nonspecific binding, the factor responsible for restrictions on the lowest level of 
detection. Insights into the role of rotation rate, incubation time, and label concentration on 
nonspecific binding have the potential to significantly improve the limit of detection for all 
immunoassays. 
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Figure Captions 
Figure 1. Schematic of analyte and ERL binding to a rotating capture substrate. 
Figure 2. Results from the SERS-based immunoassay detection of rabbit IgG based on a 12-
h sample incubation and a 12-h label incubation using stagnant solutions. 
Figure 3. Dose-response curves for SERS-based detection of rabbit IgG with 12-h and 10-
min incubation times under stagnant conditions for sample binding and ERL labeling. The 
SERS intensity is that of the v5(N02) at 1336 cm"1. The dashed lines represent the lowest 
detectable signal (blank signal plus 3 times its standard deviation). The inset is the same data 
set zoomed at lower SERS intensities to showcase the response for the 10-min incubation. 
Figure 4. Dose-response curves for the SERS-based detection of rabbit IgG comparing the 
results for stagnant antigen incubation (12 h) to substrate rotation (800 rpm, 10 min). The 
substrate was incubated with ERLs for 12 h under static conditions.cThe SERS intensity is 
that of the v^(N02) at 1336 cm"1. The dashed lines represent the lowest detectable signal 
(blank signal plus 3 times its standard deviation) for each assay. 
Figure 5. Dose-response curves for the SERS-based detection of rabbit IgG comparing the 
results for control conditions (see text), static antigen binding (12 h) with ERL rotation (800 
rpm, 10 min), and antigen and ERL rotation (800 rpm, 10 min). The SERS intensity is that of 
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the Vs(NC>2) at 1336 cm'1. The dashed lines represent the lowest detectable signal (blank 
signal plus 3 times its standard deviation) for each assay. 
Figure 6. The effect of rotation on rabbit IgG bound to the capture substrate. All sample 
incubations were performed under stagnant conditions for 12 h. The SERS intensity is that of 
the v,(N02) at 1336 cm"1. 
Figure 7. The effect of rotation rate and incubation time during the ERL labeling step on the 
SERS signal. All sample incubations were performed under stagnant conditions for 12 h. The 
SERS intensity is that of the v,(N02) at 1336 cm"1. 
Figure 8. Dose-response curves for the SERS-based detection of rabbit IgG comparing the 
results for a control assay requiring 24 h (12-h capture step and 12-h labeling step) to those 
obtained with optimized rotation (800 rpm) performed in 25 min (10-min capture step and 
15-min labeling step). The SERS intensity is that of the v,s(N02) at 1336 cm"1. The dashed 
lines represent the lowest detectable signal (blank signal plus 3 times its standard deviation) 
for each assay. 
Figure 9. The SERS intensities obtained for assays of rabbit IgG in a serum matrix. The 
samples were incubated for 12 h with the sample and ERLs under stagnant conditions or 
rotated at 800 rpm for 10 min in sample and for 15 min in ERLs. The SERS intensity is that 
of the v,(N02) at 1336 cm"1. 
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CHAPTER 6: CONCLUSIONS AND PROSPECTS 
General Conclusions 
The ultimate goal of this dissertation has been to develop a highly sensitive, rapid 
diagnostic immunoassay relying on SERS for readout. This goal has been achieved through 
the combined works presented in Chapters 2-5. As part of this effort, Chapter 2 began by 
modifying a SERS-based immunoassay strategy previously developed within our group such 
that the assay protocol could be universally applied for the detection of many analytes. This 
detection scheme employed extrinsic Raman labels (ERLs) for the identification and 
quantification of analyte bound to an antibody-modified gold substrate. Chapter 2 reported 
the first demonstration of low level detection of an intact viral pathogen in a sandwich 
immunoassay format based on a SERS readout method. As a consequence of detailed 
investigations regarding solution pH, ionic strength, blocking buffers, and surfactants, this 
method resulted in a limit of detection of 106 TCIDso/mL, and is therefore competitive with 
other viral assay methods, such as fluorescence and microcantilevers, which have limits 
between 10 and 10 TCIDso/mL. This detection limit can be further conceived as the 
detection of only -70 feline caliciviruses when considering the sample area interrogated by 
the laser spot. While respectable, lower detection levels are always desirable, and as 
presented in Chapter 1, it is possible to improve the sensitivity of this method by increasing 
the signal of the ERL or decreasing the nonspecific binding. Moreover, the incubation time 
for sampling and labeling required ~24 h while the readout was performed in 1 s. Thus, it 
was determined from Chapter 2 that efforts should be placed on reducing the incubation time 
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in addition to improving the label intensity. These conclusions were the motivation for the 
investigation into the surface enhancement mechanism and the search for a methodology to 
reduce the assay time presented in Chapters 3-5. 
In an effort to fully exploit the potential of SERS as a sensitive readout technique, 
experiments were carried out to further examine details related to the enhancement 
mechanism with respect to the possible plasmon coupling of the ERLs with the underlying 
gold substrate. The results of these studies were presented in Chapter 3. This paper found that 
the absorption peak undergoes a red shift as the nanoparticle size increases and the 
nanoparticle-substrate separation distance decreases. Furthermore, a red shift was discovered 
for nanoparticles of the same size immobilized on a gold substrate compared to a silver 
substrate. This study also found that the greatest SERS enhancement factor occurs for a 
substrate prepared with an SPR peak between the excitation and scattered wavelength, at 
-660 nm. Thus, the SERS intensity can be optimized by varying the nanoparticle size, gap, 
and substrate material. This set of data is the first experimental evidence for the dependence 
of the SERS enhancement factor on the nanoparticle-substrate separation distance and the 
most convincing argument yet in support of theoretical prediction that the maximum 
enhancement occurs when X,SPR = (A.excitation + s^cattering)/2. These results lay the foundation 
necessary to design an optimized assay with the potential to measure SERS from a single 
ERL in our SERS-based immunoassay. 
Chapter 4 explored the use of substrate rotation to increase antigen flux to the capture 
surface in a solid phase immunoassay. Initial investigations into rotation-induced flux 
utilized atomic force microscopy (AFM) for the label-free detection of porcine parvovirus 
(PPV) which isolates a single binding step for full characterization of the flux. The flux of 
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the antigen was systematically controlled via rotation rate and incubation time and resulted in 
a standardless method for quantification utilizing well-established hydrodynamic flow 
theory. The developed theory was used to predict and design optimized immunoassays which 
led to an improvement in the analytical performance of the AFM-based immunoassay as well 
as a decrease in incubation times. 
The technology developed in Chapter 4 for decreasing the binding time of the antigen 
binding step was extended in Chapter 5 to the labeling step for the SERS-based format. 
Systematic studies of the influence of rotation on antigen and label binding led to an 
optimized immunoassay yielding a tenfold decrease in the limit of detection (i.e., ~1Q ng/mL 
to ~1 ng/mL) and a reduction in the assay time from 24 h to 25 min compared to a static 
immunoassay. The sensitivity of SERS-based readout, coupled with the short incubation 
times achieved with rotation, promises great potential for playing a significant role in the 
bioanalytical arena. 
Prospects 
There are several fundamental and practical challenges that must be addressed 
concerning the union of SERS detection and substrate rotation in order to increase the 
likelihood of receiving widespread attention. Even with the decreased assay time, throughput 
is limited by the current experimental setup since samples must be rotated serially. There are 
three approaches capable of realizing increased throughput. First, an array of rotating rods 
could be machined to have individual capture substrates in separate sample solutions. 
However, this would require bulky instrumentation and multiple sample solutions. Second, a 
capture substrate could be fabricated to contain an array of many antibodies for various target 
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pathogens. This second approach, requiring a single sample solution and simple 
instrumentation, is more appealing, but presents challenges associated with preparing an 
array of compositionally unique elements. Nevertheless, experiments are underway to 
develop facile preparative techniques in order to apply substrate rotation to a multiplexed 
capture substrate. A more intriguing approach to increase throughput would be to take 
advantage of the narrow Raman band widths to facilitate simultaneous detection of multiple 
analytes without the hassle of capture substrate addressing. Presently, knowledge of unique 
labels is limited, however, and much more attention must be given to label identification. 
Regardless of which avenue leads to a successful multiplexed assay, coupled with the 
reduced assay times via substrate rotation, clinical sample throughput would greatly benefit 
from this exciting new technology. 
One of the most stimulating insights into the mechanism of SERS enhancement 
presented in Chapter 3 was the discovery of an enhancement dependence on nanoparticle-
substrate separation distance. It was concluded that larger enhancement factors are obtained 
as the gap distance is minimized. This finding has rather profound implications on substrate 
design and suggests the potential for increased signals. With the current design, the ERL is 
separated from the gold capture substrate by two antibodies, the analyte, and two organic 
monolayers. It is possible that replacing antibodies with much smaller biorecognition 
elements, such as aptamers, much larger signals could be realized. The findings from Chapter 
3 also illustrate the need to consider the analyte size. Detection of larger analytes may benefit 
from the use of larger ERLs to maintain the optimum SPR due to an increased nanoparticle-
substrate gap distance. 
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It is arguably more important to concentrate research efforts on decreasing the signal 
due to nonspecific binding than to raise the Raman signal with optimized surface 
enhancement. Currently the limit of detection in the SERS-based assay is dictated by the 
level of nonspecific binding. In Chapter 5 it was found that labeling under convective 
conditions reduces nonspecific binding. Further investigation into the role of rotation rate, 
incubation time, and label concentration on nonspecific binding are currently being pursed in 
our laboratory. These insights into the mechanism of nonspecific binding are not only valid 
for the SERS-based assay utilized throughout this dissertation, but have the potential to 
significantly improve the limit of detection for all sandwich-type immunoassays. 
